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Abstract 
 
 
 Colorectal cancer is the second leading cause of cancer related deaths in the United States.  
Approximately 80% of all colon cancers are associated with a mutation in the Adenomatous polyposis 
coli (APC) tumor suppressor gene.  We study the intracellular functions of normal APC and how loss of 
APC function leads to the formation of precancerous polyps in the intestines of mice and humans.  The 
studies presented here are particularly concerned with the role of APC in maintenance of homeostasis in 
the intestinal epithelium.  I have identified a double-negative feedback loop between APC and a 
sequence specific RNA binding protein, Mushashi-1 (MSI1).  I hypothesize that this feedback loop serves 
to maintain a critical balance and that disruption of this balance leads to loss of homeostasis and 
ultimately tumorigenesis in the intestinal epithelium.  Studies described here and by others have shown 
that MSI1 is a target of β-catenin transcriptional activation through the canonical Wnt signaling 
pathway. My work has demonstrated that APC mRNA is a target of MSI1 binding and translational 
repression.  Further study has indicated that MSI1 binding also results in stabilization of the APC mRNA, 
presumably as a rapid response mechanism to repress Wnt signal transduction once the signal is no 
longer present.  Finally, my studies indicate that MSI1 expression is stimulated by the transcription 
factor c-MYC, the most commonly deregulated human oncoprotein.  Though overexpression of c-MYC 
stimulates MSI1 expression, c-MYC expression is not stimulated by loss of APC in our cell culture system.  
The implication is that c-MYC stimulation of MSI1 expression may only occur in tumors with deregulated 
c-MYC expression.  The studies presented here have uncovered novel molecular mechanisms involved in 
regulation of the canonical Wnt signaling pathway in the intestinal epithelium, thereby expanding the 
potential methods by which deregulation of this pathway contributes to colorectal carcinogenesis.  
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Colorectal Cancer 
 Colorectal cancer is the second leading cause of cancer related death in the United States.  
There has been significant progress made in the past thirty years regarding the successful treatment of 
colorectal malignancies.  In the mid-1970s the overall 5-year survival rate was approximately 50%, but 
by 2008 this rate had risen to greater than 65% [1].  Though the post-diagnostic survival has increased, 
there is still significant morbidity associated with treatment.  The standard treatment for colorectal 
cancer is surgical resection of the tumor followed by adjuvant chemotherapy [2].  Surgical outcomes 
range from almost complete recovery of normal bowel function to complete colectomy depending upon 
site and severity of the disease.  Typical chemotherapeutics are toxic to both normal cells and cancer 
cells.  Even with recent developments in molecular screening and more personalized chemotherapy 
regimens, a significant number of patients will have recurrent disease [3].   
Along with increasing success in the treatment of colorectal cancer, scientists have made 
progress in understanding the development of colorectal tumors [4, 5], with recent insight regarding the 
cellular and molecular mechanisms of intestinal epithelial morphogenesis.  Of particular importance is 
the identification of stem/progenitor cells of the intestinal epithelium [6-8].  There is still much to be 
learned about the development of normal intestinal epithelium from stem/progenitor cells to mature 
absorptive and secretory cells.  Understanding the molecular mechanisms involved in this development 
will help us to grasp the abnormalities in these processes that ultimately lead to colorectal 
carcinogenesis. 
 
Anatomy of the Intestinal Epithelium 
 The luminal surface of the intestine is covered by a single layer of cuboidal epithelial cells [4].  
Epithelia, which cover the outside surfaces of the body, are in a constant state of mitotic turnover.  
Stem/progenitor cells divide asymmetrically on a regular, but relatively infrequent, basis and this 
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asymmetric stem cell division produces phenotypically different daughter cells  [9, 10].  One daughter is 
a regeneration of the slow cycling stem cell, which remains in the stem cell compartment, called the 
stem cell niche.  The stem cell niche has a specific microenvironment with specialized signals, such as 
opposing Wnt/bone morphogenetic protein (BMP) gradients, which maintain the multipotency of these 
cells [10].  The other product of an asymmetric stem cell division enters the rapidly proliferating transit 
amplifying (TA) cell compartment.  TA cells reproduce rapidly, but remain in a relatively undifferentiated 
state [5].  This rapid proliferation is typically accompanied by migration away from the stem cells niche.  
Once TA cells reach a critical distance from the stem cell niche, where their microenvironment is 
dramatically different, proliferation slows and maturation occurs [5].  Fully differentiated epithelial cells 
have a finite life span during which they perform the functions necessary to maintain the integrity of the 
epithelium.  The life of a differentiated epithelial cells ends with apoptosis and removal from the 
epithelium [10]. 
 The intestinal epithelium is organized into sac-like structures, known as crypts, which extend 
away from the luminal surface (Fig. 1.1A & B).  Recently, two populations of intestinal cells residing at or 
near the base of the crypt have been determined to be stem/progenitor cells ([6, 7]; Fig. 1.1A).  The first 
intestinal stem cells identified were the crypt-base columnar cells (CBCs) residing between the Paneth 
cells at the base of the small intestinal crypt [6].  These cells were marked by the specific expression of 
the Lgr5 gene and were shown to regenerate all of the differentiated cell types in the intestinal 
epithelium under normal growth conditions.  Because these cells cycle on a regular basis in order to 
maintain the intestinal epithelium, these cells were classified as the “active” stem cells [10].  Shortly 
after the discovery of the CBCs as the active stem cells in the adult intestinal epithelium, another stem 
cell population with the ability to regenerate the entire intestinal epithelium was discovered.  These 
cells reside at the +4 position of the crypt, just  above the Paneth cell compartment, and are identified 
by the specific expression of Bmi1 or the mouse homolog of DCAMKL-1 [7, 8].  In contrast to the CBCs, 
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these cells do not cycle under normal intestinal conditions.  Instead, cell cycle is activated by intestinal 
injury.  Thus, this stem cell population has been classified as the “quiescent” stem cell population [10].   
In the case of either of these two intestinal stem cell populations, asymmetric division produces 
the rapidly proliferating TA cells which divide and migrate up the crypt, away from the stem cell niche.  
There are three main intracellular signal transduction pathways involved in the division and 
differentiation of the intestinal epithelium: Wnt, BMP and Notch [reviewed in [4, 5]].  Briefly, opposing 
Wnt and BMP gradients define the epithelial stem cell niche ([10]; Figure 1.1C).  In the case of the 
intestinal epithelium, strong Wnt signaling is required for stem cell proliferation, thus the Wnt signal is 
strongest at the base of the crypt [4, 6, 10].  The opposing BMP signal is most highly expressed from the 
stroma of the villi and thus, intracellular BMP signaling activity is highest in the more differentiated cells 
of the crypt that are closer to the luminal surface [5, 11].  This opposing interaction between Wnt and 
BMP gradients is thought to be the signal for differentiation in the intestinal epithelium [10].  The Notch 
signaling pathway also plays a role in development of mature intestinal epithelium [5].  Notch differs 
from Wnt and BMP in that the ligands for the Notch receptor are not soluble, but are cell membrane-
bound [12].  Thus, Notch signaling requires cell-cell contact.  In general, Notch signaling has been shown 
to maintain cells in an undifferentiated state [13, 14].  Specifically in the intestine, Notch signaling has 
been shown to influence the decision between the two major differentiated cell types in the intestinal 
epithelium [15, 16].   
Approximately two-thirds of the way up the crypt differentiated intestinal epithelium can be 
detected [17].  There are two major cell lineages in the intestinal epithelium, absorptive and secretory.  
In the small intestine, the secretory cells include goblet cells, enteroendocrine cells and Paneth cells.  
The colon does not have Paneth cells.  Each differentiated cell type is readily identifiable by molecular 
markers [4]. 
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 Mutations of genes involved in pathways leading to proliferation and differentiation result in 
tumor formation from the crypt compartment [4].  Colorectal cancer is an excellent model for genetic 
studies of cancer development.  Morphological staging of colorectal cancers is highly correlated with 
genetic alterations that have occurred [18-20].  There are five signaling pathways that have been shown 
to be important for colorectal cancer development: Wnt, Ras, PI3 Kinase, TGFβ and p53 [21].  While 
mutations that drive the progression of tumors occur in variable order and frequency, it was recognized, 
even before the specific gene was identified, that mutations in the chromosomal region that contains 
the tumor suppressor Adenomatous Polyposis coli (APC) were important for initiating colorectal 
tumorigenesis [18, 22].  It is now known that the tumor suppressor APC is mutated in over 80% of all 
colorectal tumors and these initiating mutations result in the deregulation of the canonical Wnt 
signaling pathway [23, 24].  Thus, while the alterations to components of the other pathways are 
required for tumor progression, deregulation of Wnt signaling is the initiating event in most colorectal 
tumorigenesis.  This underscores the importance of understanding the functional interactions of APC in 
the intestinal epithelium. 
 
History of the Adenomatous Polyposis Coli gene 
 In the late 1980s the discovery of the first tumor suppressor gene, retinoblastoma (Rb), sparked 
a search for recessive mutations within inherited cancers [25-27].  During this time, allelotype studies of 
chromosomes from human colorectal tumors were revealing that a strict pattern of allelic deletion was 
associated with severity of these tumors [18, 22].  Colorectal tumorigenesis involves a step-wise 
progression from hyperplastic epithelium to premalignant adenomatous polyps to adenocarcinoma 
([18]; Fig. 1.2).  Even early on in the study of colorectal carcinogenesis it was recognized that these 
different morphological stages were associated with definable genetic aberrations [18, 22].  In the late 
1980s the loss of chromosome 5q21 was identified as an initiating event in colorectal tumorigenesis [18, 
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22].  In the early 1990s mutations associated with an inherited form of colorectal cancer known as 
Familial Adenomatous Polyposis coli (FAP) were identified [28-30].  These mutations were mapped to a 
gene on chromosome 5q21 and the affected gene was named after the resultant disease, Adenomatous 
Polyposis Coli (APC).  Over 20 years and 6000 publications later, mutation of the APC locus is still defined 
as the initiating mutation in over 80% of all colorectal cancers, inherited and sporadic alike [31, 32]. 
 
APC Gene Function and Tumorigenesis 
 Although identified as a causative genetic change in what was recognized at the time as the 
most common form of hereditary colorectal cancer, the function of the APC gene product remained 
elusive for several years.  It was not until the late 1990s when the canonical Wnt/Wingless signaling 
pathway was further delineated that the APC protein was recognized as an antagonist of this pathway 
[23, 24].  Shortly after its identification, APC was shown to bind the E-cadherin- associated protein, β-
catenin [33].  The complexing of APC and β-catenin is regulated, in part, by the serine-threonine kinase 
GSK3β [34] and results in targeting β-catenin for ubiquitin-mediated proteasomal degradation [35-37].  
β-catenin was shown to be involved in cell-cell adhesion and was also shown to be a transcriptional 
activator through its homology to the Drosophila segment polarity gene, Armadillo [38] and through 
interaction with the Tcf/LEF family of DNA binding proteins [39].   APC can repress β-catenin 
transcriptional activity by sequestering nuclear β-catenin from transcription co-factor TCF/LEF-1 [40, 41] 
and also by associating with transcriptional repressors β-TrCP, C-terminal binding protein, and histone 
deacetylase [42, 43].  Truncation mutations of APC found in colorectal cancers result in deregulation of 
β-catenin transcriptional activation [23, 24].   
The role of β-catenin as a transcriptional co-factor led to the discovery of genes activated by β-
catenin [44-49].  The first gene identified as a target of β-catenin transcriptional activation, c-Myc, is the 
oncogene that is most commonly deregulated in human cancers and is well known to stimulate cell 
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proliferation [44].  Cyclin D1 was also shown to be upregulated by transcriptionally active β-catenin [45, 
46], though not without controversy [50].  Further study of the canonical Wnt signaling pathway has 
clarified this tumor suppressor function of APC and the carcinogenic outcomes associated with its loss 
from colonic epithelial cells.  Loss of functional APC results in the deregulation of β-catenin 
transcriptional activation and uncontrolled proliferation through overexpression of target genes that 
drive proliferation of the intestinal epithelium. 
 
The Canonical Wnt Signaling Pathway 
 The previous section was a historical account of the discovery of the role of APC in the 
Wnt/wingless signaling pathway.  We now know that the transduction of a Wnt signal is much more 
complex than what I described.  The canonical Wnt signaling pathway is conserved in all metazoans [51] 
and one of the most widely studied intracellular signaling pathways. Results from studies in standard 
genetic model organisms such as Drosophila and C. elegans have been readily translated into 
mammalian systems and applied to human disease [52].  Described here is a basic overview of the 
current understanding of Wnt signal transduction as it relates to the intestinal epithelia [Figure 1.3, 
reviewed in [53] and [54]].  The signaling molecules, Wnts, are soluble growth factors that are secreted 
by many different cell types including stromal cells underlying the base of intestinal crypts [4].  Wnt is 
recognized on the cell surface by the Frizzled (FZD) family of seven-transmembrane receptors and this 
binding initiates a cascade of events that ultimately results in expression of genes that stimulate cell 
proliferation and inhibit differentiation, the Wnt target genes [17, 44-49].  When FZD is in a Wnt 
unbound state, a cytoplasmic complex involving APC, GSK3β, the scaffold protein Axin and casein kinase 
1α (CK1α) binds and phosphorylates β-catenin, targeting it for ubiquitin-mediated proteolytic 
degradation.  This so-called β-catenin destruction complex maintains low levels of cytoplasmic β-
catenin, thus inhibiting the expression of Wnt target genes (Fig. 1.3A).  Once Wnt binds to FZD, the 
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receptor rapidly complexes with an LRP5/6 co-receptor and recruits Dishevelled (DVL) and Axin to the 
plasma membrane [55].  LRP binding to Axin inhibits the kinase activity of the β-catenin destruction 
complex [56].  This Wnt signal results in hypophosphorylated β-catenin which is not ubiquitinated and 
accumulates in the cytoplasm.  Cytoplasmic accumulation of β-catenin results in its translocation into 
the nucleus.  Nuclear β-catenin functions as a co-transcription factor with the TCF family of DNA binding 
proteins [39]. Generally, β-catenin functions to stimulate target gene expression, which in turn functions 
to stimulate cell cycle progression (Fig. 1.3B).  This is a skeletal description of the canonical Wnt signaling 
pathway that does not account for interactions with other intracellular signaling pathways that can also 
affect Wnt pathway activity. 
 It has been hypothesized that the events following the receipt of Wnt signal on the cell surface 
ultimately result in disrupted assembly of the β-catenin destruction complex [54].  Experimentally, 
either disruption of complex assembly or inhibition of its various components have been shown to 
stimulate aberrant Wnt target gene expression ([53, 54], Chapter 2) and this is the primary known 
mechanism by which APC mutations result in colorectal cancers.  Biallelic mutation of APC disrupts the 
assembly of the β-catenin destruction complex, leading to aberrant Wnt signaling and ultimately to 
uncontrolled cell proliferation and loss of differentiation in the intestinal epithelium [17].  The question 
of why mutation of APC is so strongly associated with colorectal cancers will be reviewed in the 
following section.      
 Eighty percent of all colorectal cancers, including both hereditary and sporadic cancers, involve 
mutations in APC that result in the loss of its tumor suppressor function [31, 53, 54].  Carcinogenic 
mutations in APC are typically frame-shift or nonsense mutations that result in a premature stop codon 
[57].  In the majority of colorectal cancers, the stop codons produced by these mutations are clustered 
in the region between codons 1250 and 1550 of the APC gene which is referred to as the mutation 
cluster region [58].  The implication is that proteins produced from most mutant APC genes are 
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truncated by half when compared with the wild-type proteins.  Colorectal cancer-associated APC 
truncations lack all of the Axin binding sites and most of the β-catenin interaction domains, the 20 
amino acid repeats (Figure 1.4).  As illustrated in the previous discussion of the Wnt signaling pathway, 
the loss of this ability of APC to interact with Axin and/or β-catenin is catastrophic to the regulation of 
the Wnt signaling cascade.  Indeed, the loss of APC in colonic epithelium has been shown to result in the 
deregulation of Wnt signaling [23, 24] and lost control of proliferation and differentiation [17].     
Why are loss-of-function mutations in APC so highly correlated with colorectal cancers?  While 
this question is difficult to answer, it does emphasize the importance of the Wnt signaling pathway in 
regulation of homeostasis in the colonic epithelium. APC is thought to function as a scaffold to bring 
GSK3β and β-catenin into close enough proximity for the regulatory phosphorylations to occur [54].  
While it is likely that APC function in the β-catenin destruction complex extends beyond that of a 
scaffold protein, in tumors in which APC mutations occur, it has been shown that the loss of both alleles 
of APC is required to initiate tumorigenesis.  Of the roughly 20% of colorectal cancers with wild-type 
APC, around 50% have activating mutations in the gene encoding β-catenin, CTNNB1 [59].  This implies 
that deregulation of Wnt signaling through the loss of APC or activation of β-catenin contributes to the 
initiation or progression of 90% of all colorectal tumors, again underscoring the importance of the Wnt 
signaling pathway in the intestinal epithelium. 
         As described above, the most well defined tumor suppressor function of APC is as an antagonist of 
the canonical Wnt signaling pathway.  APC is a relatively large protein of 2843 amino acids and 
approximately 312 KDa.   Reviewed extensively by van Es, et al. [2001; [32]], APC has multiple well-
defined intracellular roles, with some intracellular functions yet to be revealed.  The finding of APC in 
the nucleus underscores the need to consider APC as a multifunctional intracellular component.  APC 
has been shown to shuttle between the nucleus and cytoplasm [60-62].  APC is too large to passively 
transit the nuclear envelope.  Nuclear export signals and nuclear localization signals have been identified 
10 
 
near the N-terminus and in the central region, respectively [60, 62].  As mentioned, one proposed 
function of nuclear APC is to bind DNA-associated β-catenin and inhibit β-catenin transcriptional activity 
by sequestration and removal from the nucleus [40, 42].  Recently, APC has been shown to interact with 
the DNA decatenation enzyme Topoisomerase IIα (TopoIIα) in the nucleus [63].  Previously observed 
functions of APC in the G2/M cell cycle transition have been attributed to the APC-TopoIIα interaction 
[64].  The nuclear function of APC illustrates its importance outside the canonical Wnt signaling pathway 
and should be considered when assessing intracellular functions of APC. 
 One might expect that the discovery of the causative gene for colorectal cancer would have led 
quickly to a cure for the disease.  Unfortunately, we are 20 years from the identification of APC and its 
role as a suppressor of colorectal cancer initiation, and the disease still has a significant impact on the 
population in the US.  The difficulty with treatments aimed at APC stems from its nature as a tumor 
suppressor.  Since functional APC is lost in colorectal cancers, traditional targeted therapies which seek 
to inhibit target activity are not effective in this system.  Replacement of a genetic loss-of-function has 
yet to be shown as a viable option for treating human cancers.  Thus, we collectively turn our focus to 
genes and gene products that interact with APC, in the hopes of finding the critical gain-of-function 
events that result from APC loss-of-function.  In this way the standard therapeutic strategy of target 
inhibition could be employed as a means to attenuate the effects of loss of APC tumor suppressor 
activity. 
 
Musashi1 
 The musashi (msi) gene locus was first identified and cloned from a P element transposon 
mobilization screen in Drosophila [65].  The gene is so named because of the phenotype observed in 
adult flies homozygous for mutant msi alleles.  The dorsal portion of the thorax (notum) of an adult fly 
contains mechanosensory organs consisting of one shaft cell (bristle) per socket.  In msi mutant animals, 
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it was found that many sockets contained two bristles.  The gene name is attributed to the great 
samurai warrior Musashi Miyamoto who instituted a fighting style that involved the use of two swords 
[65].  A protein domain structure was deduced from the cDNA sequence and was predicted to contain 
two RNA-binding domains because of homology with known RNA-binding proteins [66]. 
 Musashi (MSI) protein is required, along with Seven in absentia (SINA), for proper eye 
development in Drosophila [67].  These studies indicated that the products of the tramtrack (ttk) gene 
were regulated by MSI and that MSI and SINA are required for proper differentiation of photoreceptor 
cells.  Further study of the bristles indicated the mechanism by which MSI regulates the expression of ttk 
([68], Figure 1.5).  Asymmetric division of the sensory organ precursor cell (SOP) leads to the production 
of the IIa shaft-socket precursor and IIb neuron/glial precursor daughter cells [65, 68].  These cells can 
be distinguished by the presence of the ttk gene product, TTK69, in IIa only [68].  Studies indicated that 
the production of TTK69 was inhibited by the sequence-specific binding of MSI to the 3’ untranslated 
region (3’UTR) of the ttk69 mRNA and subsequent inhibition of its translation.  These data indicated that 
MSI played a key role in the determination of cell fate during Drosophila nervous system development 
[68].  
 Concurrent with the Drosophila studies, mammalian homologs of MSI were identified and tested 
for RNA binding activity [69].  Mouse studies demonstrated that Msi1 binds to Numb mRNA, which 
encodes a Notch signaling antagonist, and inhibits its translation.  The result of Msi1 depression of 
Numb is an activation of intracellular Notch signal [69].  Subsequent studies indicated that Msi family 
proteins maintain the undifferentiated nature of neural stem cells and related this functional activity of 
Msi1 to its inhibition of Numb expression [70].  Thus, in mammalian cells, high levels of Msi1 result in 
increased Notch signaling, through the translational inhibition of Numb.  In general, cells with high 
Notch signaling activity are less differentiated [13, 14]. 
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Musashi1 as a Stem Cell Marker 
As described above, MSI function was first elucidated in the sensory organ precursors of adult 
Drosophila [65].  Shortly thereafter it was observed that the mammalian homolog, Msi1, was highly 
expressed in neural precursor cells in the mouse brain, but expression was lost in the differentiated 
neurons and glial cells [71].  These data, along with the link between Msi1 and maintenance of cells in an 
undifferentiated state through its interaction with the Notch signaling pathway, led to the description of 
Msi1 as a stem cell marker in the mammalian nervous system [66, 70].  In the case of the nervous 
system specific precursor cells, their multipotency had been established, they were readily identifiable, 
and the expression of Msi1 was easily observed.  The definition of Msi1 as a stem cell marker was 
generalized and applied to epithelial tissues [66].  While this generalization likely helped to drive 
discovery of the stem cells in the intestinal epithelium [6-8], in retrospect it is not likely that Msi1 is a 
good stem cell marker in the intestinal epithelium, as its expression is not limited to one of the 
previously described stem cell compartments [72].  
Studies on the expression of Msi1 in the intestines of mice and humans have shown mixed results 
with respect to Msi1 as a stem cell marker in the intestinal epithelium.  Early studies showed high levels 
of Msi1 mRNA and protein in developing crypts of embryonic mice [72].  The data indicated a sensitive 
and specific detection of Msi1 protein and mRNA, but the pattern of expression was not restricted to 
the putative stem cell compartment.  Other studies demonstrated the presence of Msi1 in the crypt-
base columnar cells (CBCs) that were later shown to function as intestinal epithelial progenitors [73].  In 
this case, Msi1 co-expression with another putative stem cell marker, Hes1, was correlated with stem 
cell specificity.  Unfortunately, the co-expression did not occur in the CBCs, but instead in the cells just 
above the Paneth cells, the location of the so called quiescent, Bmi1/DCAMKL-1-expressing stem cells [7, 
8].  Evaluating these data retrospectively with the knowledge of the epithelial progenitor cells that have 
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recently been identified [6-8] it is clear that Msi1 expression is not restricted to the stem cell 
compartment.  Rather, it appears that Msi1 is present in both the quiescent and cycling stem cells as 
well as in the transit-amplifying cells.  Many subsequent studies have successfully identified Msi1-
positive cells driving epithelial regeneration in the intestine both under normal conditions [74], after 
injury [75] and in genetic models where aberrant crypt formation occurs [76].  More recent studies of 
primary human colon cells from surgical resections showed MSI1 expression in sorted stem cell 
populations and indicated the presence of MSI1 is necessary for stem cell properties [77].  These mouse 
and human studies implicate a significant role for Msi1 in regeneration of crypt structures.   
Disease-based studies have indicated high Msi1 expression in intestinal tumors from mice and 
humans [72, 78] and have shown reduction of MSI1 levels in human colon cancer cells lines decreases 
tumorigenicity in a mouse xenograft model [78].  In a PTEN knock-out mouse model, cells expressing 
Msi1 were sufficient to drive intestinal polyp formation [76]. These data further solidify the importance 
of proper regulation of Msi1 to the maintenance of homeostasis in the intestinal epithelium. 
The conclusions from this evaluation of the literature on Msi1 are two-fold.  First, looking back on 
data acquired prior to the identification of stem cells in the intestinal epithelium it is now clear that Msi1 
is not restricted to the stem cell compartment.  Thus, while it is important for crypt regeneration and 
maintenance, Msi1 is not a classic stem cell marker in the intestinal epithelium.  Other stem cell markers 
such as Lgr5, Bmi1, and DCAMKL-1 are more strict indicators of the two stem cell subpopulations [6-8].  
Secondly, it is apparent from the reviewed studies that Msi1 plays a significant role in the regeneration 
and maintenance of the intestinal epithelium [77].  Overexpression of Msi1 has been implicated in 
aberrant crypt formation and intestinal tumorigenesis in both mice and humans [72, 76, 78].  Thus, Msi1 
association with the stem cell compartment is critical for maintaining homeostasis in the intestinal 
epithelium and deregulation of Msi1 expression may be sufficient for initiation of intestinal 
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tumorigenesis.  The rest of this introduction will focus on the molecular mechanisms involved in the 
regulation of Msi1 expression specifically in the intestinal epithelium. 
In vivo Interaction between APC and MSI1   
 The finding that mutations resulting in the loss of APC tumor suppressor function are so highly 
correlated with the initiation of colorectal tumors has made the APC gene and its protein product the 
topic of significant study.  Mouse models completely lacking APC have been difficult to obtain because 
germline loss-of-function mutations in APC result in embryonic lethality [79-81].  While mice 
heterozygous for mutations in Apc have served as models for colorectal tumorigenesis for over 20 years 
[79], the study of complete loss  of Apc function in the intestines of these mice is impossible.   
Only recently, a technological advance allowed analysis of complete loss of Apc in the intestines 
of mice [17].  An inducible, Apc loss-of-function model which utilizes Cre-lox technology was employed 
to assess the overall impact of the loss of Apc on the intestines of adult mice.  Adult animals 
homozygous for lox-flanked Apc (Apcfl/fl) alleles could be treated in order to induce Cre recombinase 
expression specifically in the intestine.  The subsequent Cre-induced recombination led to complete loss 
of Apc in the intestines of adult mice.  The induced Apcfl/fl mice were critically ill within five days post-
treatment.  Assessment of the intestine of these mice showed that crypts were longer and contained 
more cells indicating the expected hyperproliferation from deregulation of the canonical Wnt signaling 
pathway.  The more unexpected finding was that Apc had a significant impact on differentiation of the 
intestinal epithelium.  There was a complete loss of differentiation within the intestinal crypt as defined 
by the generalized villus marker alkaline phosphatase.  Further analysis of the Apcfl/fl intestines indicated 
a loss of proper differentiation into absoptive, goblet and enteroendocrine cells.  A microarray analysis 
was also performed on intestinal tissue from induced Apcfl/fl animals to assess the overall impact of Apc 
on gene expression in the intestine.  Of particular interest to us was an almost 13-fold increase in the 
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expression of Msi1.  As discussed previously, Msi1, while not restricted to the stem cell compartment, is 
associated with maintenance of stem cells.   
 The main focus of the Neufeld lab is to evaluate alternative functions of APC in the intestinal 
epithelium as a means to further elucidate its tumor suppressor function.  Previous work has made 
significant inroads into the function of APC in the nucleus [64, 82, 83] and identification of novel APC 
interactions [63, 84] as a means of understanding the role of APC in normal intestinal homeostasis and 
carcinogenesis.  As was previously mentioned, there is difficulty in therapeutic replacement to 
compensate for a loss-of-function, however, understanding potential gains-of-function that result could 
allow for standard therapeutic inhibitors to be employed.  My specific interests have stemmed from the 
observation of a potential interaction between Apc and Msi1 in mouse intestine [17] and I sought to 
evaluate the molecular mechanisms involved using cultured human colonocytes. 
 
 A Novel Double-negative Feedback Circuit Involving APC and MSI1 
 My first challenge was to select a cell line in which to perform our assessment of the APC-MSI1 
interaction.  The first obstacle came about because of a desire to study this interaction under normal 
cellular conditions.  There are no normal human intestinal cell lines. The only intestinal cell lines 
available are cancer cell lines.  As mentioned above, 80% of all colorectal cancers have biallelic 
mutations in APC.  This translates into the intestinal cell lines as well.  Secondly, of the few cell lines that 
contain wild-type APC, there are typically mutations in other components of the canonical Wnt signaling 
pathway, particularly the gene for β-catenin [85].  We expected the canonical Wnt signaling pathway to 
play some role in the interaction between APC and MSI1.  In order to evaluate this interaction in a 
relatively normal background, we used a cell line, termed HCT116βw, engineered in the Vogelstein lab 
[86].  The parental HCT116 colon cancer cell line expresses wild-type APC, but contains a mutant allele 
of CTNNB1 (β-catenin).  In order to normalize the canonical Wnt signaling pathway, a CTNNB1 deletion 
16 
 
series was produced and a cell line hemizygous for wild-type CTNNB1 (HCT116βw) was isolated.  These 
cells are derived from human colon epithelium and express wild-type canonical Wnt signaling pathway 
components.  I tested the these cells using the TOPFlash reporter assay and demonstrated that they 
have normal β-catenin transcriptional response to canonical Wnt signal (Chapter 2). 
 Once I characterized the Wnt signaling response in the HCT116βw cell line, I assessed the 
interaction between APC and MSI1 (Chapter 2) by recapitulating the results observed in mice using 
human cell culture experiments.  Short-hairpin RNA (shRNA) knockdown of APC led to an increase in 
MSI1 protein and mRNA.  Further supporting the idea that MSI1 is a target of β-catenin transcriptional 
activation, I demonstrated that over-expression of stabilized β-catenin led to a dose-dependent increase 
in MSI1 protein.  Concurrent with my work, studies in mouse intestine demonstrated that a 7Kb region 
corresponding to the Msi1 promoter could drive luciferase expression in response to β-catenin over-
expression [87].  These data combined, demonstrate that MSI1 is a previously unidentified target of the 
canonical Wnt signaling pathway.  Thus, deregulation of the canonical Wnt signaling pathway by the loss 
of functional APC leads to deregulation of MSI1 expression (Chapter 2).  
 A further probe into the mechanism of the APC-MSI1 interaction led us to identify a double-
negative feedback loop between APC and MSI1.  Again, employing shRNA to specifically knock down 
MSI1 levels, I observed a coincident increase in APC protein, but no change in APC mRNA levels (Chapter 
2).  Transient over-expression of Msi1 cDNA decreased APC protein and actually slightly increased APC 
mRNA.  These data are consistent with the previously described function of Msi1 as a translational 
inhibitor [68, 69, 88].  The mechanism of MSI1 translational inhibition has been delineated [89].  Briefly, 
MSI1 binding to the 3’UTR of its target mRNA binds to poly(A) binding protein (PABP) and inhibits its 
interaction with eukaryotic initiation factor 4G (eIF4G).  The interaction of PABP with eIF4G is critical for 
initiation of translation.  Luciferase reporter assessment using the 3’UTR of APC (as described in Imai 
2001 [69]) demonstrated that APC mRNA is a target of MSI1 binding and translational silencing.  This 
17 
 
type of reciprocal regulation, termed “double-negative feedback”, results in a bistable circuit that is 
often observed in biological systems balancing on the edge of considerable change. 
Implications of APC-MSI1 Double-negative Feedback in the Intestinal Epithelium   
 The occurrence of bistable biological systems has been extensively reviewed by James Ferrell 
(Current opinion in cell biology, 2002 [90]).  To summarized his definition, a bistable circuit is one in 
which feedback produces a balance between two states, i.e., on or off, stop or go.   External signals 
result in an imbalance in the feedback that leads to a stable, long-term, signal-independent response.  
The simplest, non-biological, analogy is that of a light switch [91, 92].  Your finger, the signal, pushing 
the light switch up stimulates a cascade of events that ultimately result in a response, the light turns on.  
This response then becomes independent of the initial signal such that the light remains on when you 
remove your finger. The light remains in the “on” state until this state is actively reversed, i.e., your 
finger pushes the light switch down.  Bistable circuits require either positive feedback, i.e., an effector 
activates its own stimulation, or double-negative feedback, i.e., an effector represses its own inhibition.   
Other hallmarks of bistable circuits are a toggle-like response to the signal, high sensitivity to the signal 
and ultimate acquisition of independence from the original signal.  It is intuitive that, in isolation, both 
positive feedback and double-negative feedback circuits have all of the characteristics of bistability.  
However, these circuits are not necessarily bistable when placed into the context of a biological system.  
In fact, understanding the regulation of bistability may be just as important as understanding its role in 
controlling complex biological processes. 
 While understanding the functional aspects of bistability is important, another, potentially more 
intriguing question presents itself: Why would biological systems adapt a signal transduction circuit that 
becomes signal independent and has the potential for irreversibility?  The answer may come from the 
significant complexity of cellular processes such as proliferation and differentiation.  Both of these 
processes require significant changes to the intracellular environment.  Recent studies have 
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demonstrated that multiple bistable events are required for cells to progress through cell cycle 
checkpoints to the ultimate end of cell division [93].  Not only are these bistable events necessary, but 
they are required for progression through the cell cycle.  It is likely that bistable molecular switches are 
responsible for many of the processes that result in global cellular change.  In the instance of 
differentiation, the need for a signal independent response is implicit.  Particularly in the intestinal 
crypts, differentiated cells are likely in different environments than their undifferentiated ancestors, yet 
the program for differentiation must be maintained independent of the original stimulating signal and 
persist for the life of the cell.   
 
Summary 
 MSI1 is a sequence-specific RNA binding protein that functions to inhibit translation of target 
mRNAs.  This function is conserved from flies to humans ([68, 69], Chapter 2).  Early on, the effect of 
Msi1 expression on the cellular environment was best defined in the developing nervous system [67, 68, 
70] where Msi1 was convincingly defined as a stem cell marker.  These findings have resulted in the 
application of Msi1 as a generalized stem cell marker, especially in the intestinal epithelium [72, 74, 94].  
While Msi1 is expressed in the stem cell compartment in cycling tissues, such as the intestinal 
epithelium, its expression is not restricted to the stem cell compartment [72].  Thus, while the 
interaction between Msi1 and the Notch signaling pathway does help maintain cells in a relatively 
undifferentiated state [70], this activity does not appear to be restricted to stem cells in the intestinal 
epithelium.   
Early studies of Msi1 in the intestinal epithelium have demonstrated that Msi1 expression is up-
regulated in mouse and human intestinal tumors [72, 78].  Furthermore, siRNA knockdown of MSI1 in 
human colorectal cancer cells decreased their tumorigenicity upon Xenograft [78].  More recent 
mechanistic studies of Msi1 in the intestinal epithelium have further expanded our understanding.  Msi1 
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has been identified as a target gene of the canonical Wnt signaling pathway in mouse intestine [87] and 
in cultured human colonocytes (Chapter 2).  Studies of the interaction of MSI1 with the Wnt signaling 
pathway have revealed a double-negative feedback circuit with the tumor suppressor APC (Chapter 2).  
In this circuit, the function of APC as an antagonist of the canonical Wnt signaling pathway leads to 
inhibition of MSI1 transcription; MSI1 inhibits translation of APC mRNA.  While further study is 
warranted, the implications of these results on the prevention and treatment of colorectal cancers are 
potentially far reaching.  The loss of APC, an initiating event in 80% of all colorectal cancers, results in 
the deregulation of MSI1.  The chain of events leading to highly proliferative, undifferentiated colorectal 
tumors may hinge on this deregulation of MSI1 activity.  Flipping the “bistable switch” of the APC-MSI1 
double-negative feedback circuit to the “off” position, by inhibiting MSI1 activity, may be the key to 
successful treatment of colorectal cancers.    
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Figure 1.1.  The intestinal epithelium is organized into crypt structures.  A:  The anatomy of the small 
intestinal epithelium is shown.  Specifically, the two stem cell populations are identified with respect to 
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the Paneth cell compartment and the transit-amplifying zone.  The differentiated intestinal epithelial 
cells cover the villi which extend into the lumen of the intestine.  Cells are programmed for a finite life 
span and somewhere in the villus structure, they die by apoptosis and are sloughed into the lumen of 
the intestine.  B:  The structure of the colonic epithelium is shown identifying the same structures as in 
A.  There are two major differences between the small intestinal and colonic epithelia.  First, though the 
Lgr5+ active stem cells reside in the same position, there are no Paneth cells in the colon.  Secondly, the 
surface of the colon is smooth, there are no villi.  Fully differentiated colonic epithelium die and are 
sloughed as in the small intestine.  C:  The structural depiction of the small intestinal epithelium is 
shown next to indications of the soluble signal gradients that regulate proliferation and differentiation in 
the intestinal epithelium.  As indicated in the text, Wnt concentration is highest at the base of the crypt 
and decreases toward the villus.  Alternatively, BMP signal is strongest in the villus and decreases 
toward the base of the crypt.  The synchronization of these two soluble signal gradients results in a line 
of differentiation (dashed line).  Cells above this line arrest, become quiescent with regard to cell cycle, 
and terminally differentiate into the absorptive or secretory lineages.  Not depicted is the contribution 
to Notch signaling to the determination of cell fate in the intestinal epithelium.  (Adapted from Sancho, 
E.,  Batlle, E., and Clevers, H., Ann. Rev. Cell. Dev. Bio., 2004 [4]) 
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Figure 1.2.  Progressive genetic alterations define colorectal tumorigenesis.  The morphological staging 
of colorectal cancer is shown as a progression along the arrow.  At each stage of the initiation and 
progression of tumor growth, genetic alterations (lightning bolts) occur that allow the tumors to be 
staged genetically as well as morphologically.  The red asterisk indicates that, while other genetic 
alterations may occur in varying order during tumor progression, the vast majority of colorectal tumors 
initiate from loss of function mutations in APC.  (Adapted from Fearon, E.R. and Vogelstein, B., Cell, 1990 
[18]) 
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Figure 1.3.  Wnt signal is transduced through β-catenin and regulated by the APC-containing complex.  
The canonical Wnt signaling pathway is depicted.  A: When the Frizzled (FZ) receptor is unbound, the 
APC-containing β-catenin destruction complex is intact and functional.  The complex, which includes 
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APC, Axin, GSK3β and CK1α, binds to and phosphorylates β-catenin.  This phosphorylation targets β-
catenin for ubiquitination and degradation in the proteosome (dashed line).  Wnt target gene expression 
is low when β-catenin is actively degraded.  B: In the presence of soluble Wnt signal, Wnt-FZ binding 
recruits LRP5/6 and Dishevelled (DVL) to the receptor complex.  The receptor complex recruits the APC-
complex to the plasma membrane and the binding of LRPs and DVL to Axin inactivates the kinase activity 
of the β-catenin destruction complex.  Hypophosphorylated β-catenin builds up in the cytoplasm and is 
subsequently translocated into the nucleus.  In the nucleus, β-catenin functions as a transcription co-
factor with the TCF/LEF-1 family of DNA binding proteins and stimulates target gene expression.  Typical 
Wnt target genes, such as Cyclin D1, c-MYC and MSI1 (identified recently), function to stimulate cell 
proliferation. 
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Figure 1.4.  APC protein domain structure. APC is a large, multi-domain protein.  The domain map of the 
APC protein is depicted with the codon/amino acid designation below.  The black and red hatched box 
indicates the mutation cluster region in which premature stop codons occur as the result of the majority 
of carcinogenic APC mutations.  These mutations result in truncation of the C-terminal half of the 
protein, removing the Axin binding (SAMP repeat) domain and the bulk of the β-catenin binding (20 
amino acid repeats) domain.  Truncation of APC inhibits its ability to participate in the β-catenin 
destruction complex and inactivates this complex (Fig. 1.3).  This leads to deregulation of the Wnt 
signaling pathway and loss of proliferative control.  (Adapted from Fernhead, N., et al., Human 
Molecular Genetics, 2001 [57])  
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Figure 1.5.  msi is a translational regulator of cell fate.  A:  The msi gene was identified based on a 
double-bristle phenotype obtained from a P element excision screen in Drosophila.  The loss of Glia (G) 
and Neurons from the neuronal lineage in the bristle structure led to the duplication of the non-
neuronal Sheath (Sh), Socket (So) and Shaft (Sf) cells and thus two bristles.  B:  The two cell lineages that 
compose the bristle come from a single sensory organ precursor cell (SOP).  The SOP gives rise to two 
daughter cells, IIa and IIb, which ultimately give rise to the non-neuronal and neuronal lineages, 
respectively.  The molecular determinant of SOP daughter cell fate is the presence of TTK69 protein.  
Both IIa and IIb have ttk69 mRNA, but protein is only produced in the IIa cell, the precursor to the non-
neuronal cells.  In the IIb cell, the translation of ttk69 mRNA is repressed by MSI.  MSI repression of 
ttk69 expression determines the neuronal cell fate in the IIb progeny.  Homozygous loss of function of 
msi allows the production of TTK69 in both SOP progeny and duplication of the non-neuronal cell 
lineage. (Adapted from Okabe, M. et al., Nature, 2001 [68]) 
 
27 
 
 
 
 
 
Chapter 2 
 
Novel Double-negative Feedback Loop between Adenomatous Polyposis Coli 
and Musashi1 in Colon Epithelia   
28 
 
The data and opinions in this chapter were published previously [95] and reformatted for this 
dissertation: 
 
Spears, E. and K. L. Neufeld (2011). "Novel double-negative feedback loop between adenomatous 
polyposis coli and Musashi1 in colon epithelia." The Journal of biological chemistry 286(7): 4946-4950. 
 
 
Abstract 
 
 Loss of tumor suppressor adenomatous polyposis coli (APC) is thought to initiate the majority of 
all colorectal cancers. The predominant theory of colorectal carcinogenesis implicates stem cells as the 
initiating cells. However, relatively little is known about the function of APC in governing the 
homeostasis of normal intestinal stem cells. Here, we identify a novel double-negative feedback loop 
between APC and a translation inhibitor protein, Musashi1 (MSI1), in cultured human colonocytes. We 
show APC as a key factor in MSI1 regulation through Wnt signaling and identify APC mRNA as a novel 
target of translational inhibition by MSI1. We propose that APC/MSI1 interactions maintain homeostatic 
balance in the intestinal epithelium. 
 
Introduction 
 
Two subpopulations of stem cells have recently been identified in the intestinal epithelium [6-8]. 
It has been shown that loss of Apc in one of these stem cell subpopulations results in intestinal 
adenomas [96]. Loss of Apc throughout the small intestine leads to expansion of undifferentiated, stem 
cell-like epithelium into the normally well differentiated villus compartment and a 12-fold increase in 
Msi1 mRNA [17].  
Musashi proteins function to inhibit translation initiation by binding to the 3-untranslated region 
(3-UTR) of target mRNAs and competing with poly(A)-binding protein for eukaryotic initiation factor 4G 
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binding [89]. The two best characterized targets of mammalian MSI1 are the Notch antagonist Numb 
and the cyclin- dependent kinase inhibitor p21 [69, 88]. Msi12 maintains cells in a more undifferentiated 
state, in part, through activation of Notch signaling and cell cycle progression [66]. MSI1 is expressed in 
the putative intestinal stem cells [75, 76].  
The most well defined function for APC is as an antagonist in the canonical Wnt signaling 
pathway [5]. A complex containing APC, Axin, and glycogen synthase kinase 3 binds to and 
phosphorylates β-catenin, leading to ubiquitination and degradation of β-catenin by the proteasome. 
Wnt binding to its cognate receptor or APC loss each lead to β-catenin accumulation in the cytoplasm, 
translocation into the nucleus, and interaction with co-activator TCF/LEF-1, resulting in transcription of 
Wnt target genes. In addition, there is evidence that nuclear APC also brings the transcriptional 
repressor C-terminal binding protein to the TCF-β-catenin complex [42], sequesters β-catenin from 
TCF/LEF-1 [40] and facilitates nuclear export of β-catenin [60, 61, 97]. Approximately 80% of all 
colorectal cancers are associated with mutation of both APC alleles, resulting in APC truncation and loss 
of this tumor suppressor function [19]. 
In the current study, we used cultured human colonocytes to examine the functional 
relationship between APC and MSI1, first observed in mouse intestines [17]. Msi1 was recently shown to 
be a Wnt target gene in mouse intestinal epithelium [87], and our studies in human colon cells support 
this finding. Our study further reveals that MSI1 regulates APC levels, providing the first evidence for a 
double-negative feedback loop between APC and MSI1. We have confirmed that MSI1 regulates APC 
translation. We hypothesize that this double-negative feedback system is central to the maintenance of 
homeostasis, the critical balance of proliferation and differentiation, in the intestinal epithelium. 
 
Experimental Procedures 
Plasmids and Cloning. 
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SureSilencing short-hairpin RNA (shRNA) plasmids (SuperArray, Frederick, MD) were used to 
reduce levels of APC and MSI1. For Msi1 overexpression, pCDNA3-Flag-Msi1 (Flag-Msi1) and pCDNA3-
Flag-Msi1mutR1 (Flag-mutR1) were generously provided by Hideyuki Okano (Tokyo, Japan). The mutR1 
Msi1 mutant contains three phenylalanine-to-leucine substitutions in the first RNA binding domain [69]. 
These phenylalanines are required for RNA binding and subsequent translational inhibition by Msi1, and 
these substitutions have been shown to ablate binding of the mutant to Numb mRNA [69, 98]. Mouse 
Msi1 cDNA was employed for these studies. Mouse and human cDNAs are 93% identical, and the 
proteins differ by two amino acids (Q127H and T251S) that do not affect the first 
RNA recognition motifs, required for RNA binding [98]. The Numb 3’-UTR-luciferase reporter, pGVP2-
Numb, was provided by H. Okano. The APC 3’-UTR luciferase reporter was made by replacing the Numb 
3’-UTR in pGVP2-Numb3’-UTR with the APC 3-UTR amplified from HCT116βw genomic DNA using the 
following primers: APC 3’-UTR (forward), 5’-AAGAGAGGAAGAATGAAACTAAG-3’ and APC 3’-UTR 
(reverse), 5’-GCATGTATCTCCATTGTTTATG-3’.  The pGVP2-APC 3’-UTR 5’ deletion mutant was made by 
cutting the APC 3’UTR reporter DNA with the XbaI restriction enzyme, gel-purifying the fragments, and 
religating the truncated APC 3’-UTR into the pGVP2 backbone.  
In order to look at Wnt target gene expression in HCT116βw cells we overexpressed a mutant 
form of exogenous β-catenin that is not phosphorylated by the APC containing complex and is thus not 
targeted for ubiquitin-mediated degradation described previously [99].  As with the other 
overexpression constructs, this β-catenin is Flag-tagged  and contains a S33F and T45A substitutions 
which alter the GSK3β phosphorylation sites and stabilize the protein in a transcriptionally active state 
(Flag-β-catenin Ub-).  This stabilized, exogenous β-catenin can stimulate target gene activity regardless 
of the presence or activity of the APC-containing destruction complex.  
Cell Culture and Transfection. 
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HCT116βw cells, a generous gift from Bert Vogelstein, were cultured as described [86].  NIH3T3 
cells (ATCC) were grown in DMEM:10% Cosmic Calf® serum. GeneExpresso (Lab Supply Mall, 
Gaithersburg, MD) was used to transfect cells at 30–40% confluency, grown in 6-well plates. For RNA 
interference, 2.5 µg of shRNA plasmid was used; for overexpression, 0.5 µg and 1 µg of Flag-Msi1 or 
Flag-mutR1 were used with DNA content equalized by the addition of pCDNA3.1. 
 
Protein Analysis. 
Cells were washed twice with cold PBS and then collected in reporter lysis buffer (Promega, 
Madison, WI) with protease inhibitors 48 h after transfection. Lysates were sonicated (10 s, Output 1) 
using a Heat Systems-Ultrasonics, Inc. cell disruptor (Plainview, NY). An aliquot was immediately 
removed, added to 4X protein sample buffer, and heated to 95°C for SDS-PAGE. Another aliquot was 
added to 1 ml of TRIzol reagent (Invitrogen), incubated at room temperature for 5 min, and stored at -80 
°C for RNA isolation. Proteins were separated using SDS-PAGE and 7% polyacrylamide gels and blotted 
onto nitrocellulose. Antibodies used for protein detection were as follows: APC [M2-APC [63]], rabbit 
anti-MSI1 (locally produced), and α-tubulin (12G10, Developmental Studies Hybridoma Bank (DSHB), 
University of Iowa. Images acquired with a Kodak image station 4000R (Molecular Imaging Systems, 
Rochester, NY) were analyzed using the ImageJ 1.4.1o software (rsb.info.nih.gov/ij). 
  
RNA analysis. 
 Quantitative real-time reverse transcriptase polymerase chain reaction was used to assess 
mRNA content. RNA was isolated from TRIzol solution following the manufacturer’s instructions. First 
strand cDNA was prepared from 0.5 µg of RNA using 200 units of M-MuLV reverse transcriptase and 
Random 6 primer (New England Biolabs, Ipswich, MA). Quantitative PCR for APC, MSI1, and 
hypoxanthine-guanine phosphoribosyl-transferase (HGPRT; internal control) was performed using the 
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DyNAmo HS SYBR Green quantitative PCR kit (New England Biolabs) and analyzed on a DNA Engine 
Opticon 2 thermal cycler for continuous fluorescence detection (Bio-Rad). Target mRNA estimates were 
made by comparing fold change to levels in control transfections using the ∆∆C(T) calculation method. 
 
Luciferase Reporter Assay. 
 Numb and APC 3’-UTR-Luciferase reporters were co-transfected with Flag-Msi1 or FlagmutR1 
and Renilla luciferase (transfection control) expression constructs with total DNA adjusted to 2 µg using 
pCDNA3.1 vector. 48 h after transfection, cell lysates were prepared as described for protein analysis, 
and luciferase activity was assessed using a Dual-Luciferase reporter assay system (Promega) and a 
LMAXII384 microplate reader (Molecular Devices, Sunnyvale, CA). Firefly luciferase data were 
normalized to Renilla luciferase and expressed as a percentage of the negative control (vector only) 
luminescence. MSI1 shRNA experiments were performed similarly with 3 µg of total DNA. 
 The TOPFlash luciferase reporter system has been adopted as a standard for detecting β-catenin 
driven transcriptional activation [23].  The reporter used for the current experiments is a 16X TOPFlash 
reporter meaning that it contains 16 TCF/LEF-1 binding sites upstream of a minimal promoter driving 
expression of Firefly luciferase and was a generous gift from Randall T. Moon (Seattle, WA).  A FOPFlash 
reporter, which contains scrambled sequence in the enhancer region, is used as a negative control to 
show that the change in luciferase activity is specifically due to β-catenin transcriptional activity.   The 
TOPFlash reporter was co- transfected with plasmids expressing stabilized, Flag-tagged β-catenin (Flag-
β-catenin Ub-), LEF-1, and APC shRNA and firefly luciferase activities were assessed as described in 
Materials and Methods.  The TOPFlash reporter was also used to assess the upregulation of β-catenin 
transcriptional activation in Wnt3a treated cells.  Cell treatment involved mixing Wnt3a or control 
medium with fresh culture on dividing cultures 24 h after transfection with TOPFlash reporter and 
incubating for another 24 h. 
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Wnt3a Conditioned Medium. 
 Wnt3a conditioned medium was derived from mouse L cells stably expressing a transgene for 
the secreted signal [100].  As a control, L cells lacking the Wnt3a transgene were grown in parallel.  
Wnt3a expressing and control L cells were a generous gift from Shinji Takada (Kyoto, Japan).  Briefly, 
Wnt3a secreting cells, and counterpart control cells, were cultured in McCoy’s 5A with 10% FBS and 
expanded through multiple passages until the desired cell volume was reached.  Cells were allowed to 
grow for 24 h after the last passage and medium was collected from cells that were 50-75% confluent.  
Wnt3a and control media were stored at -80oC in aliquots until use. 
  
Results 
 
Loss of APC Leads to Increased MSI1 Protein and mRNA in HCT116βw Cells. 
 In mice, inducible, intestine-specific loss of Apc led to a greater than 12-fold increase in Msi1 
mRNA in intestinal tissue. To further evaluate the interaction between APC and MSI1 in human 
colonocytes, we used HCT116βw cells, which have a stable karyotype and express wild-type APC. 
HCT116w cells were also manipulated to only express wild-type β-catenin [86]. The intact Wnt signaling 
pathway in HCT116βw cells is critical for our studies because both APC and MSI1 can impact Wnt 
signaling [4, 87]. APC mRNA and protein levels were both reduced in HCT116βw cells transiently 
transfected with plasmids expressing shRNA corresponding to the APC mRNA sequence (Fig. 2.1). This 
knockdown of APC resulted in a reproducible increase in MSI1 protein (Fig. 2.1B) and a 2–4-fold increase 
in MSI1 mRNA (Fig. 2.1C). 
 
Canonical Wnt signaling is functional and stimulates MSI1 expression in HCT116βw cells. 
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 In order to demonstrate that the canonical Wnt signaling pathway is functional and stimulates 
target gene expression in HCT116βw cells we employed the TOPFlash luciferase reporter system.  The 
TOPFlash system was developed as a read-out for β-catenin transcription activation, the major end-
point of the canonical Wnt signaling pathway, and is used extensively in the field [23].  Co-transfection 
of the TOPFlash plasmid with a mutant CTNNB1 cDNA results in the expression of a Flag-epitope tagged, 
stabilized, transcriptionally active form of β-catenin [Flag-β-catenin Ub-; [99]]. As expected, this 
stabilized β-catenin increases the luciferase activity and supplementation with LEF-1 further increased 
the transcriptional read-out (Fig. 2.2A).  Co-transfection of the TOPFlash reporter with APC shRNAs leads 
to a 14-fold increase in luciferase activity in these cells (Fig. 2.2B).  Finally, exposure of transfected cells 
to Wnt3a conditioned medium also increased TOPFlash activity (Fig. 2.2C). Because the source of Wnt3a 
was conditioned media harvested from Wnt3a-expressing cells, it is expected that there was depletion 
of growth factors and nutrients from this “used” culture medium.  Thus, in the case where 75% Wnt-
conditioned media was mixed with 25% fresh media, the added Wnt3a did not appear to compensate 
for the depletion of other growth factors that might stimulate proliferation and the TOPFlash activity 
was not as high as with a 50:50 mix.  These data indicate that β-catenin transcriptional activation is 
properly functioning in the HCT116βw cells and is readily stimulated by loss of APC tumor suppressor 
function. 
 Not only is the canonical Wnt signaling pathway functional in HCT116βw cells, but it stimulates 
MSI1 expression.  Figure 2.2 D and E show results from overexpression of Flag-β-catenin Ub- on MSI1 in 
these cells.  Western blot analysis and subsequent quantification of protein band intensities indicate 
that MSI increases with increasing amounts of Flag-β-catenin Ub-.  Recently Msi1 was shown to be a 
direct target of β-catenin transcriptional activation in mice [87] and our results indicate the same in 
human colonocytes. 
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Loss of MSI1 Leads to Increased APC Protein in HCT116βw Cells. 
 The canonical Wnt signaling pathway is functional and stimulates target gene expression in 
HCT116w cells (Fig. 2.2, A–C). Moreover, MSI1 expression is up-regulated in HCT116βw cells with 
overexpressed β-catenin (Fig. 2.2, D and E). MSI1 has recently been shown to activate the Wnt signaling 
pathway [87]. To determine whether this regulation involves APC, we reduced MSI1 protein and mRNA 
in HCT116βw cells by transient transfection with plasmids expressing shRNA corresponding to the MSI1 
mRNA sequence (Fig. 2.3). This knockdown of MSI1 resulted in a reproducible increase in APC protein 
(Fig. 2B) but no significant change in APC mRNA level (Fig. 2.3C), consistent with MSI1 functioning as a 
translational inhibitor of APC. 
 
Msi1 Overexpression Decreases APC Protein in HCT116βw Cells. 
 Consistent with the loss-of-function data, overexpression of wild-type but not mutant Msi1 in 
HCT116βw cells led to a decrease in APC protein (Fig. 2.4, A and B). Unexpectedly, APC mRNA did not 
decrease but rather showed an increase at the highest level of exogenous Msi1 (Fig. 2.4C). These data 
are consistent with the known function of MSI1 as a translational inhibitor. Even in the presence of 
increased APC mRNA, Msi1 overexpression led to decreased APC protein levels.  
 
MSI1 Inhibits Translation of mRNA Containing the APC 3’-UTR. 
MSI1 binds the 3’-UTR of target mRNAs such as Numb and Cdkn1a and inhibits their translation 
[69, 88]. The sequence (G/AU1–5AGU) has been established as a MSI1 consensus binding sequence [MCS; 
[69]. The APC 3’-UTR contains four putative MCSs, two near the 5’ end and two closer to the 3’ end (Fig. 
2.5A). Of the four potential MCS, only the first is conserved in sequence and position in human and 
mouse (Fig. 2.5B). This first MCS is predicted to locate in a hairpin structure, which is optimal for MSI1 
binding (Fig. 2.5C). 
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To test whether APC is a novel target of MSI1 translational inhibition, we generated a luciferase 
reporter that incorporated the entire APC 3’-UTR or a deletion mutant lacking the first two potential 
MCSs. NIH3T3 cells were used for this study because they lack endogenous MSI1 [69]. Cells transfected 
with the APC 3’-UTR luciferase reporter showed a marked reduction in luciferase activity when co-
transfected with the Flag-Msi1 expression construct (Fig. 2.5D). This reduction was similar to that seen 
using the Numb 3’-UTR reporter and did not occur in NIH3T3 cells expressing a mutant form of Msi1 (Fig. 
2.5D). The APC 3’-UTR reporter lacking MCS1 and -2 did not show a decline in activity significantly 
different from the complete APC 3’-UTR reporter in the presence of mutant Msi1 (Fig. 2.5D). HCT116βw 
cells transfected with the APC 3’-UTR luciferase reporter showed no significant decline in luciferase 
activity when cells co-expressed either Msi1 or mutant Msi1, nor was a decline apparent for the Numb 
3’-UTR luciferase reporter, which served as a positive control (Fig. 2.6). To examine whether 
endogenous MSI1 in HCT116βw cells was suppressing translation of the APC 3’-UTR reporter, 
endogenous MSI1 levels were reduced using MSI1 shRNA (Fig. 2.5E). Reduced MSI1 levels were 
accompanied by an increase in APC 3’-UTR reporter activity. We conclude that the dampened response 
of the reporters to MSI1 overexpression seen in HCT116βw cells likely resulted from endogenous MSI1. 
Combined, these data indicate that MSI1 regulates APC levels in HCT116βw cells through its activity as 
an RNA sequence-specific inhibitor of translation. 
 
Discussion 
 Here, we report a novel double-negative feedback loop between APC and MSI1 that has 
potential relevance to the homeostasis of intestinal epithelia (Fig. 2.7). Our data indicate that APC, 
acting through β-catenin in the canonical Wnt signaling pathway, is responsible for regulation of MSI1 in 
cultured human colonocytes. These results confirm the recent report that murine Msi1 is a direct target 
of β-catenin transcriptional activation [87] and extend these findings to human colonocytes. 
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Furthermore, we show that the APC 3’-UTR is a novel target of translational inhibition by MSI1. This 
reciprocal regulation of APC by MSI1 is likely responsible for the dramatic effect on differentiation 
observed upon Apc mutation in the adult mouse intestine [17]. Double-negative feedback is thought to 
be important in cells undergoing significant change, such as cells that are differentiating or undergoing 
asymmetric cell division, because the effect of double-negative feedback is similar to that of positive 
feedback [90]. APC is involved in regulating cell division in the intestinal epithelium through inhibition of 
Wnt signaling [101]. Loss of APC is an initiating event in a majority of colorectal cancers, further 
underscoring the importance of APC in the maintenance of the intestinal epithelium. MSI1 inhibition of 
p21 translation has been shown to increase cell proliferation [69, 88]. By activating Notch signaling, 
MSI1 has also been implicated in the maintenance of a dedifferentiated state in mammalian cells [66]. In 
the intestinal epithelium, MSI1 is present in the stem cell compartment and is predicted to have a role in 
symmetric stem cell division [72]. It is noteworthy that colorectal cancers show increased MSI1 levels, 
and decreasing MSI1 in colorectal cancer cell lines decreases tumorigenicity in mouse xenografts [78]. It 
is likely that loss of differentiation observed in vivo following induced Apc mutation results from the 
double-negative feedback between APC and MSI1 that we have now identified [17]. Imbalance in this 
double-negative feedback loop leads to loss of homeostasis in the intestinal epithelium and may 
ultimately result in cancer. Colorectal cancer is unique because APC loss is associated with ~80% of all 
disease [19]. Replacement of APC in colorectal cancers through gene therapy remains a complicated 
therapeutic strategy. Our data indicate that APC loss results in the up-regulation of MSI1 and the 
disruption of a delicate balance between these two effectors. Thus, we propose that MSI1 represents a 
potential target for future colorectal cancer therapies.  
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Figures  
 
 
Figure 2.1.  Loss of APC leads to an increase in MSI1 protein and mRNA in cultured human colonocytes. A, 
a representative Western blot reveals decreased APC protein and increased MSI1 protein in cells 
expressing either of two APC shRNAs as compared with cells with scrambled shRNA (NC). B, MSI1 and 
APC band intensities from 3 independent experiments were normalized to α-tubulin. Results are 
expressed as the percent increase in APC or MSI1 in cells transfected with APC shRNA as compared with 
cells transfected with scrambled shRNA ± S.E. C, quantitative real-time RT-PCR analysis was performed 
on cells transiently expressing APC or scrambled shRNA. Results from 3–5 independent experiments are 
expressed as average -fold change of APC- or MSI1-specific mRNA in APC shRNA transfected cells as 
compared with scrambled shRNA-transfected cells (dashed line)± S.E. 
 
  
 
39 
 
 Figure 2.2.  MSI1 is a Wnt target in HCT116βw cells.  A:  TOPFlash, a luciferase reporter for LEF1/β-
catenin activity, is up-regulated in response to β-catenin overexpression and this effect is augmented by 
exogenous expression of co-transcription factor, LEF-1.  Data are expressed as the average % increase 
from three independent experiments comparing cells transiently transfected with the indicated 
expression plasmids to cells co-transfected with empty vector ± SEM.  B:  Loss of APC by shRNA 
treatment results in increased β-catenin transcriptional activation as indicated by increased luciferase 
activity from the TOPFlash reporter system.  APC shRNA data are shown as Fold Change compared to 
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cells transfected with NC shRNA.  C: Addition of Wnt3a conditioned medium to HCT116βw cells 
increases TOPflash reporter expression.   FOPFlash control luciferase activity did not vary significantly 
from the vector only control in any of the experiments.  D: Representative western blot showing 
increased MSI1 protein cells expressing exogenous Flag-tagged, stabilized β-catenin (Flag-β-catenin Ub-).  
E:  Western blot Band intensity data from three independent experiments showing a reproducible and 
statistically significant (p << 0.05) increase in MSI1 protein level in cells expressing exogenous Flag-β-
catenin Ub-. 
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Figure 2.3.  Loss of MSI1 leads to an increase in APC protein, but not mRNA. A, a representative Western 
blot reveals decreased MSI1 protein and increased APC protein in cells expressing either of two MSI 
shRNAs as compared with cells with scrambled shRNA (NC). B, MSI1 and APC band intensities from 3 
independent experiments were normalized to α-tubulin. Results are expressed as percentage of 
increase in APC or MSI1 in cells transfected with MSI1 shRNA as compared with cells transfected with 
scrambled shRNA ± S.E. C, quantitative real-time RT-PCR analysis was performed on cells transiently 
expressing MSI1 or scrambled shRNA. Results from 4–5 independent experiments are expressed as 
average -fold change of APC- or MSI1-specific mRNA in MSI shRNA-transfected cells as compared with 
scrambled shRNA-transfected cells (dashed line)±S.E. 
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Figure 2.4.  Overexpression of Msi1 results in decreased APC protein. A, representative Western blots of 
HCT116βw cells transiently transfected with Flag-Msi1 or mutant Msi (Flag-mutR1) expression 
constructs. B, APC band intensities for the lowest Msi1 cDNA concentrations, from 5 independent 
experiments, were normalized to α-tubulin and expressed as average (ave.) band intensity ± S.E. 
Asterisks indicate a statistically significant decrease in APC band intensity from vector alone (p < 0.05) 
and Flag-mutR1 controls. Flag-mutR1 overexpression did not alter APC band intensity when compared 
with vector alone control (p > 0.4). C, quantitative real-time RTPCR analysis was used to measure APC 
mRNA in HCT116_w cells transfected with increasing concentration of Flag-Msi1 expression construct or 
empty vector. Results from 5 independent experiments are expressed as average -fold change of APC 
mRNA in Flag-Msi1-transfected cells as compared with empty vector-transfected cells (dashed line)±S.E. 
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Figure 2.5.  MSI1 binds to APC 3_-UTR and inhibits translation. A, schematic representation of mouse 
and human APC 3_-UTRs showing position of MCSs. A mutant with the first 360 bp deleted (human 3’-
UTR5’del.) was incorporated into a luciferase reporter. B, alignment of the first 360 bp of mouse and 
human APC 3’-UTR (mApc 3’UTR and hAPC 3’UTR, respectively). The asterisk indicates MCS conservation 
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in both position and sequence. C, secondary RNA structure surrounding MCS1 and -2 (shaded) as 
predicted by the RNAfold WebServer. Structural images were produced by the mfold Web Server. D, left 
panel, luciferase activity in NIH3T3 cells transfected with a luciferase reporter containing APC 3’-UTR 
(APC), APC 3’-UTR 5’ deletion (APC 5’del.), and Flag-Msi1 cDNA (Msi) or a Flag mutant Msi1 cDNA 
(mutR1). Right panel, luciferase activity in NIH3T3 cells transfected with luciferase reporter containing 
the positive control Numb 3’-UTR (Numb) and Msi or mutR1. Data are expressed as the average 
percentage of luciferase reporter activity in Msi or mutR1 co-transfected cells versus Vector alone (% 
Control ± S.E.). Co-transfection of the wild-type APC 3’-UTR construct with Flag-Msi1 significantly 
decreased the luciferase activity when compared with mutR1 co-transfectants (p < 0.05). Co-
transfection of APC 3’-UTR 5’ deletion with Msi1 did not significantly decrease luciferase activity from 
mutR1 (p < 0.05) and resulted in a significant loss of Msi1 repression (p < 0.05). E, luciferase activity in 
HCT116βw cells co-transfected with either scrambled (NC) or MSI shRNA and luciferase reporters 
containing either APC or Numb 3’-UTR. Data are expressed as average relative luminescence ± S.E. after 
normalizing for transfection efficiency with Renilla luciferase. In HCT116βw cells, reporters containing 
either the APC or the Numb 3’-UTR each produced more luciferase when co-transfected with MSI1 
shRNA than when co-transfected with scrambled shRNA (p < 0.05). 
  
45 
 
 
 
 
 
 
 
 
Figure 2.6.  APC 3’UTR reporter assay in HCT116βw cells.  Luciferase activity in HCT116βw cells co-
transfected as in Fig. 4D with luciferase reporter containing APC 3’UTR (APC) or Numb 3’UTR (left and 
right panels, respectively) and Msi or mutR1. 
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Figure 2.7.  APC-MSI1 double-negative feedback loop in human intestinal epithelium. Under normal 
cellular conditions, APC represses Wnt target gene expression by targeting _-catenin for destruction (red 
line) and sequestering nuclear β-catenin from transcription co-factor TCF/LEF-1 (not shown). In the 
presence of Wnt or following loss of APC function, β-catenin drives expression of Wnt target genes 
including MSI1 (green lines and arrows). Current studies expand this model by demonstrating that MSI1 
protein inhibits translation of APC mRNA, completing a double-negative feedback loop between APC and 
MSI1. 
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Chapter 3 
 
MSI1 Stabilizes APC mRNA  
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Abstract 
 
 MSI1 is an RNA-binding protein that binds to the 3’ untranslated region of target mRNAs in a 
sequence specific manner and inhibits their translation.  In Chapter 2 we described a unique interaction 
between MSI1 and the tumor suppressor APC in which each represses the expression of the other in a 
double-negative feedback circuit.  MSI1 bound to a specific sequence in the 3’ untranslated region of the 
APC mRNA and inhibited protein production.  Overexpression of exogenous Msi1 decreased APC protein 
levels, as expected, but APC mRNA levels increased.  The data presented here demonstrate that APC 
mRNA is stabilized by MSI1 binding.  We hypothesize that stabilization of APC mRNA by MSI1 allows a 
rapid restoration of APC protein upon Wnt removal.  The inherent bistability of a double-negative 
feedback circuit, such as the one between APC and MSI1, requires a signal, in this case Wnt removal, to 
return the circuit back to the APC dominant state.  Such a signal would involve the release of the APC 
mRNA by MSI1.  We tested whether MSI1 was inherently unstable or conditionally unstable in response 
to removal of Wnt signal.  We did not observe destabilization of MSI1, indicating that another 
mechanism is involved stimulating the release of the APC mRNA.   We expect that the stabilization and 
subsequent rapid translation of APC mRNA is the first step in response to a Wnt signal.  Further study is 
needed to understand the mechanisms involved in this process. 
 
Introduction 
 
The Musashi (MSI) family of sequence specific RNA binding proteins has been shown to 
significantly impact cell fate determination in developing central nervous systems of Drosophila and 
mice [70, 102].  The importance of Msi1 in driving epithelial regeneration in the intestines of mice has 
been established [74-76].  Msi1 has been shown to stimulate proliferation and inhibit differentiation of 
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cultured cells in which it is up-regulated [69, 88].  Mechanistic studies have revealed that these cellular 
phenotypes are the direct result of MSI1 mRNA binding and subsequent translational repression of 
target mRNAs ([69, 88], Chapter 2).  This translational repression leads to decreases in critical regulatory 
elements of the Wnt, Notch and Cyclin-dependant kinase signal transduction pathways. 
The tumor suppressor APC is mutated in approximately 80% of all colorectal cancers [31, 32].  
APC is a critical component of the Wnt signaling pathway which regulates the expression of genes 
required for cell proliferation such as Cyclin D1 and c-Myc [44-46].  Extracellular Wnt ligand results in an 
intracellular signal that inactivates a complex containing APC.  The inactivation of the APC-containing 
complex results in β-catenin-mediated transcriptional activation of target genes [103].  Recently, Msi1 
was identified as a target of the Wnt signaling pathway in mouse and human intestinal epithelium ([87], 
Chapter 2).  Moreover, APC mRNA is a target of MSI1 binding and translational inhibition resulting in a 
double-negative feedback loop indicating the potential of bistable regulation of the Wnt signaling 
pathway in the intestinal epithelium (Chapter 2). 
Our previous work showed that overexpression of exogenous Msi1 in human colon cancer cells 
leads to a decrease in APC protein, in accordance with the role of MSI1 as a translational inhibitor 
(Chapter 2).  Unexpectedly, in this same experiment, APC mRNA levels increased, indicating that MSI1 
binding to the APC 3’UTR may serve to both stabilize and inhibit translation of the APC message.  In the 
current studies we demonstrate that MSI1 binding results in stabilization of APC mRNA.  We expect that 
the stabilization of APC mRNA serves as a rapid response mechanism to turn off the canonical Wnt 
signaling pathway once the Wnt signal has been removed.  In this case, MSI1 would need to be released 
from the APC 3’UTR once Wnt signal is removed from these cells.  To this end, we also tested whether 
MSI1 is an inherently unstable protein or if MSI1 protein stability is decreased after removal of a Wnt 
signal in these cells.  This study is the first demonstration of a role for MSI1 in mRNA stabilization. 
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Materials and Methods 
 
Cell culture. 
 HCT116βw were acquired and cultured as described previously (Chapter 2).  Briefly, cells were 
cultured in McCoy’s 5A medium with 5% fetal bovine serum (FBS) at 37oC with 5% carbon dioxide.  
Experiments involving transfection and/or treatment with drug were performed in 6-well plates as 
described below. 
   
Plasmids and Transfection. 
 FlagMsi expression and RNAi knockdown experiments employed plasmids described previously 
(Chapter 2).  FlagMsi expression constructs were a generous gift from Hideyuki Okano (Tokyo, Japan).  
Cells were transfected with 1µg of FlagMsi1 expression construct or 2.5µg of shRNA construct with 
GeneExpresso lipofection reagent (Lab Supply Mall, Gaithersburg, MD) at a reagent(µL):DNA(µg) ratio of 
3.5µL:1µg.  Transfection medium was prepared by adding GeneExpresso and DNA to fresh McCoy’s 5A 
medium with 7.5% FBS.  Cells were grown in 2mL of transfection medium for 24-48 hours depending on 
experimental design.   
 
Drug treatments. 
 The RNA polymerase II inhibitor, Actinomycin D, was used to assess the stability of APC mRNA in 
response to exogenous FlagMsi1 or shRNA knockdown of endogenous MSI1.  Cells were incubated for 
40-48 hours in transfection medium prior to drug treatment.  Transfection medium was replaced with 
2mL of fresh medium containing 5µg/mL Actinomycin D.  Cells from a single well were collected 
immediately after addition of Actinomycin D (zero time point) and remaining cells were cultured under 
normal culture conditions until harvest at designated time points (Fig. 3.1).  Upon harvest, cells were 
51 
 
washed twice with ice cold PBS, collected in Reporter Lysis Buffer (Promega, Madison, WI) with protease 
inhibitors and sonicated briefly (Output 1 for 10 sec.).  100µL of cell lysate was added to 1mL of Trizol 
reagent (Invitrogen) and stored at -80oC until use. 
 Protein stability experiments employed Cycloheximide (CHX, Sigma), an inhibitor of translation.  
CHX stock was prepared in Dulbecco’s Modified Eagle Medium (DMEM) and diluted in culture medium 
to a final concentration of 100µg/mL for treatment.  The experiment sought to assess the stability of 
MSI1 protein before and after removal of a Wnt signal.  In this case, cells were treated with Wnt3a 
conditioned medium, as described below, for 24 hours.  Wnt medium was removed, cells were washed 
with PBS and fresh medium containing Cycloheximide was added.  Cells were harvested at different time 
points as described above (Fig. 3.2B).  Cells from a single well were harvested immediately after addition 
of drug (zero time point).  For protein analysis, 75µL of cell lysate was added to 25µL of 4x protein 
sample buffer immediately after sonication.  Samples were heated to 95oC for 5 minutes, centrifuged at 
maximum speed for 1 minute and stored at -80oC until use. 
 
RNA analysis. 
 Total RNA was extracted from Trizol reagent and quantitative real-time reverse transcriptase 
polymerase chain reaction (qRT-PCR) was performed to assess levels of target mRNAs as described 
previously (Chapter 2).  C(T) values for target mRNAs, APC and c-MYC, were normalized to GAPDH and 
expressed as a Fold Change from the zero time point for each target.  For MSI1 shRNA studies, MSI1 
mRNA was analyzed in zero time point samples to verify that MSI1 expression was reduced due to RNA 
interference.  MSI1 mRNA decreased by an average of 71.6% ± 6.8% (four independent experiments) in 
MSI1 shRNA treated samples as when compared to negative control shRNA treated cells.  Sequences of 
target specific primers were as follows: APC primers – forward 5’-AACTGCGGTCAAAAATGTCC-3’, reverse 
5’-TGTCAAGATCAGC-AAGAAGCA-3’; c-MYC primers – forward 5’- GAGGCTATTCTGCCCATTTG-3’, reverse 
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5’- ACCGAGTCGTAG-TCGAGGTC-3’; MSI1 primers – forward 5’-GACTCGCCGCACGACCCC-3’, reverse 5’-
GGCCACCTTAGGGTC-AATTG-3’; GAPDH primers – forward 5’-TG-CTGTTGAAGTCGCAGGAG-3’, reverse 5’-
CCAATGTGTCCGTCGTGGA-3’.  
 
Protein analysis. 
 Protein samples were separated by polyacrylamide gel electrophoresis and transferred to 
nitrocellulose membrane.  Blots were probed for MSI1 with a rabbit polyclonal antiserum produced 
locally (1:2000) and for Histone H2B (1:1000, abcam, cat. no. ab1790).   MSI1 band intensities were 
calculated using Image J software (Java 1.6.0_26, NIH, http://rsb.info.nih.gov/ij) normalized to Histone 
H2B and expressed as fold change from time zero to assess protein stability. 
  
TOPFlash Luciferase Reporter Assay. 
 The TOPFlash reporter system was used as described previously (Chapter 2) to assess Wnt 
pathway signal transduction by assessing β-catenin transcriptional activation.  Cells treated with Wnt3a 
or control conditioned medium were harvested in lysis buffer and analyzed for luciferase activity to 
demonstrate stimulation of the canonical Wnt signaling pathway. 
  
Wnt3a Conditioned Medium. 
 Wnt3a and control conditioned media were produced from mouse L cell lines as described 
previously (Chapter2).  Previous data indicated that a 1:1 volume:volume ratio of Wnt3a medium to 
fresh culture medium stimulates an optimal Wnt signaling response in HCT116βw cells.  This ratio was 
used for all subsequent experiments. 
  
Results 
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Msi1 overexpression in HCT116βw cells results in the stabilization of APC mRNA. 
 Previous studies showed that the overexpression of exogenous Msi1 in human colonocytes led 
to decreases in APC protein, consistent with the role of MSI1 as a translational inhibitor, but a 
concomitant increase in APC mRNA also occurred (Chapter 2).  This indicated that MSI1 binding to the 
3’UTR of the APC mRNA may function not only to repress APC expression, but also to stabilize the APC 
mRNA.  To test this hypothesis, we used the RNA polymerase II inhibitor, Actinomycin D in order to halt 
mRNA production in FlagMsi1-transfected cells and monitored mRNA levels over time (Fig. 3.1A).  Cells 
transfected with FlagMsi1 had significantly more APC mRNA at two and four hour time points post-
Actinomycin D treatment when compared to cells transfected with empty vector or the RNA binding-
incompetent Msi1 mutant, FlagMsimutR1.  The expected rapid degradation of c-MYC mRNA indicated 
that mRNA production had ceased following addition of Actinomycin D (Figure 3.1B).  c-MYC is an 
immediate early gene that codes for a transcription factor involved in cell cycle progression.  The activity 
of the c-MYC protein is regulated by the relatively unstable nature of the mRNA and protein [104].   
These data suggest that Msi1 binding to APC mRNA results in its stabilization. 
 In order to demonstrate that the RNA stabilization effect was due to the sequence-specific 
binding of MSI1 to its target mRNA we analyzed the effect of exogenous expression of Msi1 on c-MYC 
mRNA.  If the effect of FlagMsi1 overexpression was a generalized mRNA stabilization, then we would 
expect to see stabilization of c-MYC mRNA as well.  We observed no stabilization of c-MYC mRNA 
associated with the expression of FlagMsi1 when compared to the RNA binding incompetent mutant, 
FlagMsimutR1 (Fig. 3.1B).  This indicates a target specific stabilization of APC mRNA by Msi1. 
 Finally, we wanted to demonstrate that the stabilization of APC mRNA by MSI1 takes place 
under physiological conditions and not just a result of exogenous protein overexpression.  Since 
HCT116βw cells express detectable amounts of endogenous MSI1, we predicted that depletion of this 
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MSI1 would destabilize the APC mRNA.  Consistent with this prediction, after 4 hours of Actinomycin D 
treatment cells transfected with MSI1-specific shRNA had approximately 60% less APC mRNA than cells 
transfected with a negative control (NC) shRNA, that does not have a specific cellular target (Fig. 3.1C).  
Taken together these data indicate that the sequence-specific binding of MSI1 to the 3’UTR of APC 
mRNA not only results in translational repression (Chapter 2), but also results in the stabilization and 
accumulation of the APC mRNA. 
 
Msi1 protein is stable and this stability does not decrease in response to removal of a Wnt signal from 
HCT116βw cells. 
 We have shown previously, and have repeated the experiment here, that HCT116βw cells 
respond to treatment with Wnt conditioned medium by upregulation of β-catenin transcriptional 
activity as indicated by the TOPFlash luciferase reporter assay system (Chapter 2, Fig. 3.2A).  Given the 
potential bistability of the APC-MSI1 double-negative feedback system, it is possible that the 
stabilization of the APC mRNA by MSI1 functions as a response to Wnt signal upregulation of MSI1 
expression and subsequent downregulation of APC.  In order for the accumulated APC mRNA to be 
translated, MSI1 must release it.  We have proposed three potential scenarios by which MSI1 releases 
the APC mRNA allowing translation to initiate (Fig. 3.3).  The first and second scenarios involve MSI1 
protein stability.  In the first scenario, MSI1 protein is inherently unstable and decreased expression 
through the loss of Wnt signal is sufficient to remove it from the APC mRNA.  The second scenario 
indicates that the loss of Wnt signal is required to destabilize MSI1 protein.  In this case decreased 
expression coupled with decreased protein stability would combine to remove MSI1 from the APC 
mRNA.  In the final scenario, MSI1 protein is modified or bound in some way that would cause a 
conformational change allowing for the release of the APC mRNA.  We did not venture to test this final 
scenario in these studies, but have plans for future experiments to this end.  In the second scenario we 
55 
 
expect an observable response by MSI1 to the removal of Wnt signal.  The most obvious response would 
be a decrease in MSI1 protein stability subsequent to the removal of Wnt conditioned medium as 
indicated by the second scenario.  The destabilization of MSI1 protein after removal of the Wnt signal 
would allow production of APC protein from the accumulated APC mRNA.  This upregulation of APC 
expression would allow for regulation of the Wnt signaling cascade to be reestablished. 
 To explore the first and second scenarios relating to MSI1 protein stability, we treated cells with 
cycloheximide arrest protein synthesis.  Cells were treated with Wnt-conditioned or control medium for 
24 hours.  After this Wnt stimulation, cells were washed, treated with cycloheximide-containing medium 
and collected at different time points.  MSI1 protein stability was assessed by western blot analysis and 
normalized to Histone H2B (Figure 3.2B).  MSI1 protein was stable over the eight hour time course, 
showing no drop in normalized protein levels in control medium-treated cells.  Likewise, there was no 
change in MSI1 protein stability in response to removal of the Wnt conditioned medium.  Therefore, 
having no evidence to support the first two scenarios, we are left to test the third scenario in which 
other modifications of MSI1 are required to remove it from the APC 3’UTR and allow translation of the 
target.  Further experimentation is required to establish the response of APC and MSI1 to the 
stimulation with Wnt-conditioned medium and removal of this stimulus. 
 
Discussion 
 The importance of post-transcriptional events in regulation of cellular processes is well 
established.  RNA binding proteins play a crucial role in these events, particularly with respect to mRNA 
trafficking, stability and translational regulation [105-107].  The MSI family of sequence-specific RNA 
binding proteins has been studied in depth in neural precursor cells from flies to mammals [108].  The 
importance of MSI1 in the homeostasis of the intestinal epithelium in mammals has recently come to 
light ([76, 78, 87], Chapter 2).  There is quite convincing evidence that Msi1 levels are elevated in 
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intestinal tumors from mice [72] and humans [78].  Concurrent studies demonstrated that human colon 
cancer cells require elevated levels of MSI1 for tumorigenicity [78].  Subsequently, our lab and others 
demonstrated that MSI1 is a target of the canonical Wnt signaling pathway, which is central to the 
initiation of tumorigenesis in the intestine ([87], Chapter 2).  Our studies further demonstrated that 
MSI1 is involved in feedback regulation of the Wnt signaling pathway through translational repression of 
the tumor suppressor APC (Chapter 2).  Taken together, these data emphasize the importance of MSI1 
for proper homeostatic balance of the intestinal epithelium and suggest that deregulation of MSI1 
expression contributes to tumor development in the intestine. 
 Previously we demonstrated the presence of a double-negative feedback circuit between MSI1 
and APC in the intestinal epithelium (Chapter 2).  The potential bistablilty of this circuit has implications 
for the regulation of proliferation and differentiation in the intestinal epithelium [90].  The bistable 
nature of double-negative feedback systems indicates that these pathways exist in a toggle-like state.  
Though not yet defined experimentally, the toggle-like nature of Wnt pathway regulation through the 
APC-MSI1 double-negative feedback loop can easily be envisioned.  When an extracellular Wnt signal is 
received, the inactivation of the APC-containing complex leads to β-catenin-driven expression of MSI1 
([87], Chapter 2).  MSI1 binds to and inhibits the translation of target mRNAs, one of which is APC.  The 
loss of functional APC either decreasing expression or mutation expression leads to perpetuation of the 
Wnt signaling pathway independent of the extracellular Wnt signal ([17, 23, 24], Chapter 2).  It seems 
reasonable that, under normal conditions, there is some mechanism to reverse this signal independent 
Wnt pathway stimulation by MSI1, mostly because we know that inappropriate Wnt pathway 
stimulation, usually through biallelic mutation of APC, is an initiating event in colorectal cancer 
development [18, 23, 24, 32, 103].  It is this secondary signal that “flips the bistable switch” back toward 
APC which is the topic of these studies. 
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 During our previously studies we noticed that MSI1 upregulation in cultured human colonocytes 
led not only to decreased APC protein levels, through translational inhibition, but also to increased APC 
mRNA levels (Chapter 2).  This led us to hypothesize that MSI1 both inhibits APC translation and 
stabilizes APC mRNA, resulting in its accumulation.  We provide experimental evidence that MSI1 does 
stabilize the APC mRNA, that this stabilization is specific to the RNA binding ability of MSI1, and that it 
occurs under normal cellular conditions, not merely as an artifact of MSI1 overexpression.  
Considering the nature of bistable systems, such as the APC-MSI1 double-negative feedback 
circuit, we wondered if APC mRNA stabilization might be part of the regulatory mechanism to return the 
system back to one of APC dominance once the Wnt signal has dissipated.  If this were the case, we 
expected that the removal of the Wnt signal would create a signal that causes MSI1 to release the APC 
mRNA.  We first hypothesized that MSI1 protein is inherently unstable and that the loss of Wnt signal 
would rapidly decrease the intracellular pool of MSI1.  The data do not indicate this as cells treated with 
control medium showed no decrease in MSI1 protein levels after eight hours.  In a second scenario, we 
explored whether the loss of Wnt signal would decrease MSI1 protein stability, thus releasing APC 
mRNA for translation.  Again, our data do not support this model. 
We acknowledge that these studies have created more questions than they have answered.  Is 
there a rapid response of APC protein production after removal of a Wnt signal?  Is this response MSI1 
specific?  What is the signal that causes MSI1 to release the APC mRNA?  Post-translational 
modification?  Protein-protein interaction?  The observation that MSI1 stabilizes APC mRNA is an 
important cornerstone for the generation of these and other questions.  Further study of this system will 
help to elucidate the mechanisms involved in this complex double-negative feedback circuit which will 
be important to understanding the regulation of homeostasis in the intestinal epithelium.  Ultimately, 
we expect that this knowledge will broaden our understanding of colorectal carcinogenesis.    
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Figures  
A  
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Figure 3.1.  MSI1 stabilizes APC mRNA in HCT116βw cells. Cells transfected with FlagMsi1, MSI1 shRNA 
or controls for 40-48 hours were treated with Actinomycin D and collected for qRT-PCR analysis of RNA 
as described in Materials and Methods. A: Fold change data from qRT-PCR analysis of APC mRNA from 
cells transfected with FlagMsi1, FlagMsimutR1 (an RNA binding incompetent Msi1 mutant cDNA) or 
pCDNA3 vector showing a stabilization of APC mRNA at 2 and 4 hour time points.  B: Fold change data 
from qRT-PCR analysis of c-MYC mRNA from the same cells showing no stabilization of c-MYC mRNA.  
* Data from FlagMsi1- and FlagMsimutR1-transfected cultures show statistically significant differences 
(p < 0.05, Student’s T-test).  Error bars represent SEM from 4 independent experiments.  
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Figure 3.2.  Loss of MSI1 from HCT116βw cells destabilizes APC mRNA.  Fold change data from qRT-PCR 
analysis of APC mRNA from cells transfected with MSI1 shRNA or negative control (NC) shRNA showing a 
destabilizing effect on APC mRNA when endogenous MSI1 is decreased.  * Data from MSI1 and NC 
shRNA transfected cultures show statistically significant differences (p < 0.05, Student’s T-test).  Error 
bars represent SEM from 4 independent experiments. 
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Figure 3.3.  MSI1 protein stability does not change after removal of Wnt signal from HCT116βw cells. 
Untransfected cells were cultured in Wnt3a or control conditioned medium for 24 hours, washed, 
treated with Cycloheximide (CHX), and collected at different time points for MSI1 protein analysis.  A: 
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Cells transfected with TOPFlash reporter 24 hours prior to Wnt3a treatment were collected at zero time 
point and analyzed for luciferase activity.  The TOPFlash assay indicates that cells treated with Wnt3a 
conditioned medium have a >7 fold increase in β-catenin transcriptional activity indicating stimulation of 
the canonical Wnt signaling pathway. B:  Representative western blot of MSI1 and Histone H2B in CHX-
treated cells after wash-out of Wnt3a signal.  C:  Quantification of Histone H2B-normalized MSI1 band 
intensities showing no difference in MSI1 stability between Wnt3a and control treated cells.  Error bars 
represent SEM from 2-3 independent experiments. 
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Figure 3.4.  Multiple scenarios for the release of APC mRNA by MSI1 and subsequent stimulation of APC 
expression.  Three hypothetical scenarios for the release of APC by MSI1 after Wnt signal depletion are 
depicted.  For all scenarios the presence of Wnt signal is indicated on the left side (Wnt+) and the 
absence of Wnt signal is indicated on the right (Wnt-).  The first scenario shows inherently unstable 
MSI1 protein. In the presence of Wnt signal MSI1 expression is stimulated (Chapter 2) and MSI1 binding 
to APC mRNA is constantly replenished.  When Wnt signal is lost, MSI1 is no longer replenished and 
MSI1 bound to APC mRNA is degraded, freeing the APC mRNA for translation (the ribosome indicated by 
large and small ovals and translation is indicated by the arrow).  In the second scenario, MSI1 protein is 
conditionally unstable, with stability decreasing after Wnt signal is lost thus freeing APC mRNA for 
translation.  The third scenario does not require a change in MSI1 stability, but instead indicates a post 
translational modification of MSI1 or a third protein binding to MSI1 that causes it to release the APC 
mRNA. 
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Chapter 4 
 
c-MYC Stimulates MSI1 Expression   
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Abstract 
 
 The MYC family of transcription factors is the most commonly deregulated group of 
oncoproteins in human cancers.  c-MYC is expressed in actively proliferating tissues, such as the 
intestinal epithelium.  Studies in mice hinted of a link between c-MYC and the sequence specific RNA 
binding protein MSI1 that hinges on the tumor suppressor APC [109].  Inducible, intestine specific loss of 
Apc in mice leads to decreased differentiation, increased proliferation and a significant increase in Msi1 
expression.  These intestinal phenotypes are rescued by inducing the losses of c-Myc and Apc together.  
The data presented here indicate that c-MYC can stimulate MSI1 expression in cultured human 
colonocytes.  Because c-MYC is a stimulated Wnt target gene, decreasing APC in these cells would be 
expected to stimulate c-MYC expression.  In fact, the opposite was observed.  Reduction in APC levels, 
following introduction of specific shRNA, resulted in a decrease in c-MYC expression indicating that the 
stimulation of MSI1 by c-MYC is not a result of Wnt pathway stimulation.  This implies that c-MYC has 
the ability to stimulate MSI1 expression, but may not be involved in regulation of MSI1 expression under 
normal cellular conditions.  We propose that MSI1 regulation by c-MYC is specifically associated with 
cancers that have deregulated c-MYC.   
 
Introduction 
 
 Deregulation of the c-MYC gene is the most common genetic alteration associated with the 
global array of human cancers [110].  In contrast to other common oncogenes such as ras, deregulation 
of c-MYC is not typically associated with a point mutation which creates constituitive activity.  Instead, c-
MYC deregulation is commonly associated with overproduction of a normal protein as a result of gene 
amplification, translocation, or aberrant induction of oncogenic pathways, particularly the Wnt signaling 
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pathway, for which c-MYC is a stimulated target [44, 111].  Early studies of c-MYC revealed it as an 
immediate early response gene for growth factor signaling [112].  By definition, this indicates that c-MYC 
mRNA and protein are elevated in actively proliferating cells and low in cells that are not actively cycling, 
or quiescent [104].  Consequently, the major regulatory mechanism for c-MYC activity is the rapid 
degradation of the mRNA and protein products in normal cells [113].  Though study of c-MYC regulation 
at multiple levels is ongoing, one picture has become clear, deregulated c-MYC activity, either through 
overexpression or stabilization of the gene products, is important to the development of human cancers 
[110].  The pleiotropic nature of c-MYC indicates that its deregulation may play different roles in the 
development and progression of different cancers [110].  When studying any one of the vast array of 
human cancers, the role of c-MYC must be considered because of its prevalence as an oncogene.      
Initial studies in an inducible, intestine-specific Apc knockout system indicated that loss of Apc 
stimulates Msi1 expression in the mouse intestine [17].  This Msi1 upregulation was accompanied by 
decreased differentiation and increased proliferation in the intestinal epithelium.  Mechanistic studies of 
the regulation of MSI1 expression have linked the observed phenotypes to MSI1 by demonstrating that 
MSI1 is a target of β-catenin transcriptional activation through the canonical Wnt signaling pathway 
([87], Chapter 2).  Furthermore, we demonstrated that MSI1 feeds back to stimulate the Wnt signaling 
pathway through translational inhibition of APC (Chapter 2).  There is some indication however, that c-
Myc may play a role in the regulation of the Msi1 associated phenotypes in vivo.  Combining inducible 
loss of both Apc and c-Myc in the mouse intestine rescues the intestinal phenotypes observed in the Apc 
knockout alone [109].  These data indicate a role for c-MYC in the regulation of MSI1 expression in the 
intestinal epithelium. 
The studies in this chapter were performed to test whether c-MYC effects MSI1 expression in 
intestinal epithelial cells.  We first performed bioinformatic analyses on the putative MSI1 promoter 
region to ascertain the presence of c-MYC binding elements.  Experimentally, we tested the potential 
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impact of exogenously expressed c-MYC on MSI1 levels both by western blot analysis of whole cultures 
and through the use of immunofluorescence microscopy, comparing transfected and untransfected 
cells.  As demonstrated previously, the subject HCT116βw cell line responds appropriately to stimulation 
of the canonical Wnt signaling pathway (Chapter 2).  Since c-MYC has been shown to be a stimulated 
target of the Wnt signaling pathway [44], we tested the effect of loss of APC on expression of c-MYC in 
these cells as well, with a surprising outcome.  Contrary to expectations, we observed a decrease in c-
MYC expression in response to decreased APC levels.  Together, the data presented here indicate that 
only the overproduction of c-MYC has that ability to stimulate MSI1 expression.  These data have 
implications in the treatment of c-MYC overexpressing cancers.      
 
Materials and Methods 
 
Bioinformatics. 
 The mouse and human MSI1 genomic sequences were obtained from the UCSC Genome 
Bioinformatics website (genome.ucsc.edu).  Sequence searches and alignments were performed with 
GENtle DNA analysis software (Magnus Manske, University of Cologne). 
 
Cell culture. 
 HCT116βw were acquired and cultured as described previously (Chapter 2).  As mentioned, 
transfections were performed in 10cm2 per well 6-well plates (Chapter 3).  For immunofluorescence 
staining, a 2.2cm2 glass cover slip was ethanol/flame sterilized and placed in the bottom of the well prior 
to addition of cells.   
 
Plasmids and Transfection. 
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 The c-MYC overexpression construct from which expression of c-MYC cDNA is driven by the 
Cytomegalovirus immediate-early promoter was a generous gift from Don Ayer (University of Utah).  
The dominant negative MYC cDNA was subcloned from pGEM-T based construct into a pCDNA3 
backbone and in-frame with an amino-terminal Flag-epitope tag (Flag-dnMYC).  Transfections were 
performed as described previously (Chapter 3) and cells were grown in transfection reagent for 40-48 
hours.   
 
Protein analysis.   
Cells were harvested and lysates prepared for western blot as described previously (Chapters 2 
and 3).  MSI1 was detected on western blots using a rabbit polyclonal antiserum produced locally 
(1:2500).  β-actin was detected with a mouse monoclonal antibody from Sigma (1:1000, cat no. 
128K4813).       
Samples for immunofluorescent staining were washed twice with ice cold PBS and fixed on ice 
for 30 minutes in 4% paraformaldehyde solution in PBS with 0.1% Triton X-100.  Cells were 
permeabilized at room temperature in 0.2% Triton/TBS for 5 minutes with agitation.  Antibody solutions 
were prepared in 0.1% Triton/TBS with 1% Bovine serum albumin and 3% normal goat serum.  MSI1 was 
detected with rabbit anti-Musashi-1 polyclonal antibody (1:300, Millipore, cat. no. AB5977), MYC was 
detected with the mouse monoclonal c-Myc antibody (1:1000, 9E10, Santa Cruz Biotechnology, cat. no. 
sc-40), and Flag-dnMYC was detected with anti-FLAG M2 monoclonal antibody (1:1000, Stratagene, cat. 
no. 200472-21).  Cells fixed on coverslips were incubated with primary antibody solutions for 90 minutes 
at room temperature in a humidified chamber.  Cells were washed three times with TBS prior to 
addition of secondary antibody.  Secondary antibodies against mouse and rabbit were conjugated to 
AlexaFluor 488 and 568, respectively (1:1000 each, Invitrogen, cat. nos. A11029 and A11036).  
Secondary antibodies were applied for 30 minutes at room temperature.  During the last 5 minutes of 
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the secondary antibody incubation, DAPI was added to visualize the nuclei.  Stained cells were washed 
as before, coverslips were mounted onto slides using Pro-Long Anti-Fade reagent (Molecular Probes, 
cat. no. P7481) and slides were stored in the dark at 4oC until use.  Fluorescence microscopy was 
performed on a Nikon Eclipse 80i with an Optronics MagnaFire SP digital camera attachment.  Images 
were acquired with MagnaFire software and colors merged with Adobe Photoshop.    
 
RNA analysis. 
 Quantitative real-time reverse transcriptase polymerase chain reaction analysis of mRNAs was 
performed as described previously (Chapters 2 and 3).  C(T) values for c-MYC and APC mRNAs were 
normalized to HGPRT and expressed as fold change from NC shRNA-transfected cells as calculated using 
the ∆∆C(T) method.  HGPRT primer sequences were as follows: forward 5’-TGACACTGGCAAAAC-
AATGCA-3’, reverse 5’-GGTCCTTTTCACCAGCAAGCT-3’.  Primers for the detection APC and c-MYC mRNA 
were the same as those used previously (Chapter 3).   
 
Results 
 
The MSI1 promoter contains non-canonical Ebox elements. 
 Sequence analysis of the 7 kilobase region upstream of the human MSI1 coding region, the 
putative MSI1 promoter, identified four candidate c-MYC-binding, E-box, sequences (Fig. 4.1).  While no 
canonical E-box (CACGTG) sequences were identified, all four candidate sequences were CATGTG.  The 
MYC DNA binding complex has been shown to bind this non-canonical E-box sequence, but with a lower 
affinity than the canonical CACGTG (Young 2011).  In comparison, the mouse Msi1 promoter region 
contains three of the same non-canonical CATGTG E-box sequences.  Since MSI1 has been identified as a 
69 
 
target of the canonical Wnt signaling pathway ([87], Chapter 2), we postulate that c-MYC plays a 
supplementary role in MSI1 expression.  
 
Exogenous c-MYC expression increases MSI1 protein levels in HCT116βw cells. 
 In order to test whether MSI1 expression was responsive to changes in c-MYC levels, we 
expressed exogenous c-MYC in HCT116βw cells. Western blots from cultures transfected with c-MYC 
cDNA indicate a dose-dependent increase in MSI1 levels (Fig. 4.2A).   Immunofluorescence microscopy 
indicates that MSI1 levels are higher in cells with exogenous c-MYC than in cells in the same culture that 
were not transfected (Fig. 4.2B).  MYC was easily detected using an anti-MYC antibody (Materials and 
Methods) as there was no detectable exogenous c-MYC in these cells.   These data indicate that c-MYC 
can impact MSI1 expression and that it has a stimulatory effect. 
 
Dominant-negative MYC overexpression decreases MSI1 protein levels in HCT116βw cells. 
 A dominant-negative c-MYC cDNA, which produces a protein lacking the transactivation domain, 
was cloned into an expression vector in-frame with an amino-terminal Flag-epitope tag (Flag-dnMYC).  
To further assess the impact of c-MYC on MSI1 expression in our cell line, the dominant-negative MYC 
was employed.  Exogenous dnMYC was specifically detected using an anti-FLAG antibody (Materials and 
Methods).  Overexpression of Flag-dnMYC in HCT116βw cells led to a decrease in MSI1 levels as 
compared to untransfected cells from the same culture (Fig. 4.3).  This depression of MSI1 expression 
can be explained by the exogenous dominant negative MYC competing with any endogenous wild-type 
c-MYC for DNA binding in these cells and thus inhibiting c-MYC induced target gene expression.  These 
data further indicate a role for c-MYC in the regulation of MSI1 expression and further emphasize that 
wild-type c-MYC has a stimulatory effect on MSI1 expression. 
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c-MYC mRNA decreases in response to the loss of APC in HCT116βw cells.  
 c-MYC was the first gene whose expression was shown to be stimulated by the canonical Wnt 
signaling pathway [44].  Previous studies have shown that loss of APC in the intestinal epithelium results 
in upregulation of MSI1 expression ([17], Chapter 2).  We now know that this effect is associated with 
stimulation of β-catenin transcriptional activation through the canonical Wnt signaling pathway ([87], 
Chapter 2).  The current studies have indicated that c-MYC has a stimulatory effect on MSI1 expression.  
Based the data described above, we expected that loss of APC would result in increased c-MYC 
expression.  In fact, our data revealed the opposite effect.  An shRNA-mediated decrease in APC in these 
cells led to decreased c-MYC mRNA (Fig. 4.4).  Coupled with the observation that there is no detectable 
endogenous c-MYC in the HCT116βw cell line, these data indicate that the observed upregulation of 
MSI1 in response to the loss of APC is solely driven by the canonical Wnt signaling pathway.  Though our 
data indicate that c-MYC has the ability to upregulate MSI1 expression, this mechanism is likely not 
functional in these cells under normal circumstances.   
 
Discussion 
 
The product of the c-MYC proto-oncogene is a transcription factor with a number of cellular 
targets [114].  The results of transcriptional activations by MYC family proteins are global cellular 
changes such as proliferation, growth, and inhibition of terminal differentiation.  Deregulation of MYC 
activity, most commonly through amplification, occurs in a wide range of human cancers making it the 
most prevalent human oncogene [110, 115]. 
Studies in mice have indicated the importance of c-Myc in phenotypes observed in inducible 
Apc-/- mouse intestine.  The loss of c-Myc concurrently with the loss Apc rescued phenotypes and 
restored normal gene expression as compared to the deletion of Apc alone [109].  These data along with 
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our observation of double-negative feedback between APC and MSI1 (Chapter2) led us to investigate 
this apparent convergence of MSI1 and c-MYC at APC.                
Our data indicate that c-MYC, when overexpressed, has the ability to stimulate MSI1 expression 
in human colonocytes.  We have also demonstrated that the transactivating function of c-MYC is 
required for this stimulation through the overexpression of a dominant negative form of MYC.  These 
data are confounded by the observation that c-MYC expression is downregulated in response to loss of 
APC.  The simplest interpretation of these data is that these observations were an artifact of 
overexpression of a potent oncogene, such as c-MYC.  However, we submit that the observations from 
the dominant negative MYC overexpression, a suppression of MSI1 expression, indicate that these data 
are not merely an artifact.  It is instead likely that c-MYC has the ability to stimulate MSI1 expression, 
but that this activity is not required for the regulation of MSI1 expression under normal circumstances in 
this colon epithelial cell line with low or nonexistent c-MYC. 
Based on our data, it is likely that the normal regulation of MSI1 expression in these intestinal 
epithelial cells is independent of c-MYC transcriptional activity.  An interesting question that arises from 
these studies is: What happens to MSI1 expression in cells in which c-MYC is deregulated as is the case 
in a majority of cancers?  Given that MSI1 is involved in a double-negative feedback loop with APC and 
overexpression of c-MYC leads to increased MSI1, it is likely that deregulation of c-MYC would lead to a 
change in the balance between APC and MSI1 that would result in a cancer phenotype ([78], Chapter 2).  
There is still much work to do to test this hypothesis.  Direct study of the MSI1 promoter region, 
particularly through the deletion of the candidate E-box sequences, would indicate the importance of c-
MYC in MSI1 expression during normal and tumorigenic cell states.  In any case, the interaction of c-MYC 
with the APC-MSI1 double-negative feedback loop is an intriguing topic of study that may have 
significant impact on cancer therapeutics.   
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Figures 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 4.1.  The MSI1 promoter region contains non-canonical E-box elements.  Representative diagrams 
of human and mouse Msi1 promoter regions designating the positions of the non-canonical (CATGTG) E-
box elements.  The mouse promoter region contains three and the human promoter contains four 
putative c-Myc-binding elements. 
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Figure 4.2.  c-MYC overexpression increases MSI1 levels in HCT116βw cells.  A: Cells transfected with c-
MYC cDNA were collected and analyzed for the presence of MSI1 protein by western blot analysis of 
whole cell lysates.  (Left) A representative western blot showing an increase in MSI1 protein in response 
to increasing amounts of exogenous c-MYC with β-actin as a loading control. (Right) MSI1 band 
intensities were quantified, normalized to β-actin, and expressed as % increase over vector alone 
transfected cultures.  Error bars represent SEM from three independent experiments.  * c-MYC 
transfected cells show a statistically significant increase over cells transfected with vector alone (p<0.05, 
Student’s T-test).  B: Immunofluorescence analysis of MSI1 (red) in c-MYC–transfected (green) cells 
compared to untransfected cells in the same field.  DAPI (blue) marks nuclei of all cells in the field. 
 
  
* 
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Figure 4.3.  Exogenous dominant negative MYC decreases MSI1 levels in HCT116βw cells. 
Immunofluorescence analysis of MSI1 in Flag-dnMYC-transfected cells compared to untransfected cells 
in the same field.  Exogenous dnMYC (green) was detected using an antibody specific to the amino-
terminal FLAG epitope tag.  Endogenous MSI1 (red) was detected as in Fig. 4.2 and DAPI (blue) stained 
the nuclei. 
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Figure 4.4.  shRNA knockdown of APC in HCT116βw cells leads to decreased c-MYC expression.  
Quantitative real-time reverse transcriptase PCR analysis of APC and c-MYC mRNAs in cells transfected 
with APC shRNAs.  C(T) values were calculated for APC and c-MYC mRNAs, normalized to C(T) values for 
HGPRT mRNA and expressed as fold change from negative control (NC) shRNA-transfected cells using 
the ∆∆C(T) method.  Error bars indicate SEM for three independent experiments.  HGPRT adjusted C(T) 
values for c-MYC mRNA were significantly lower in APC shRNA-transfected cells than in negative control-
transfected cells (p-value < 0.05, Student’s T-test). 
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Chapter 5 
 
Discussion  
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Summary of Results 
 
The data presented in this dissertation have expanded our understanding of the molecular 
mechanisms involved in the maintenance of homeostasis in the intestinal epithelium and how defects in 
the process can lead to colorectal cancer.  We have demonstrated the presence of a double-negative 
feedback circuit between the tumor suppressor protein APC and the RNA binding protein MSI1 (Chapter 
2).  Furthermore, we have shown that MSI1 expression is regulated by the canonical Wnt signaling 
pathway.  The most well defined, tumor suppressor function of APC is as an antagonist of the Wnt 
signaling pathway.  In this capacity, APC functions in the degradation of β-catenin, the central 
transcription co-factor in the Wnt pathway [23, 24].  On the other side of the feedback system, we have 
demonstrated that the RNA-binding properties of MSI1 allow it to regulate APC expression.  MSI1 binds 
a specific sequence in the 3’untranslated region of the APC mRNA and inhibits translation (Chapter 2).  
This double-negative feedback system has important implications for the regulation of Wnt signal 
transduction.  By nature, a double-negative feedback circuit is bistable.  This means that it functions as a 
“toggle-like” switch in which a graded signal, upon reaching threshold intensity, causes a change in the 
state of the system that remains independently of persistence of the original signal [see “light switch 
analogy” in Chapter 1, [90, 92]].  The idea that the Wnt signaling pathway, which is critical to 
maintaining homeostasis in the intestinal epithelium [101, 116], is regulated by a bistable switch has 
important implications for the understanding of normal maintenance of the intestine as well as the 
understanding of colorectal carcinogenesis. 
One striking aspect of the APC-MSI1 double-negative feedback circuit and its role in regulation 
of the canonical Wnt signaling pathway is the potential “switch-like” nature of this system.  The 
implication is that a Wnt signal, received at the cells surface, inhibits the function of the APC-containing 
complex charged with signaling the degradation of β-catenin.  β-catenin in turn activates expression of 
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target genes, one of which is MSI1 which inhibits APC expression and consequently stimulates its own 
further expression in a self-perpetuating loop.  The question that arises is how does this system “switch” 
back to the APC-dominated state?  Under normal cellular conditions, a second signal must be received 
that allows the expression of APC and the inhibition of Wnt signal transduction through the degradation 
of β-catenin.  I expect this to be true for two reasons.  First, it is well established that inappropriate 
stabilization of β-catenin through the loss of functional APC, thus mimicking a constant Wnt signal, is an 
initiating event in colorectal carcinogenesis [reviewed in Morin 1999 [103]].  Second, study of the APC-
MSI1 interaction showed an unexpected increase in APC mRNA when Msi1 was overexpressed in our 
system (Chapter 2).  This “priming” the cell with an abundance of APC mRNA might then facilitate a 
rapid response upon Wnt signal removal. 
I decided to test whether this increase in APC mRNA in response to Msi1 upregulation 
represented a stabilization of the APC mRNA.  Using the RNA polymerase II inhibitor, Actinomycin D, I 
demonstrated that APC mRNA is stabilized in response to exogenous expression of Msi1.  Furthermore, I 
showed that this stabilization was specific to the mRNA binding capacity of Msi1, as a binding 
incompetent Msi1 mutant did not stabilize APC mRNA (Chapter 3).  I further demonstrated that shRNA-
mediated decrease in levels of endogenous MSI1 in our subject cell line resulted in destabilization of 
APC mRNA.  I hypothesize that the MSI1-specific stabilization of APC mRNA is the first step toward 
flipping the bistable switch regulating the Wnt signaling pathway back to the APC-dominated state.  
Since MSI1 binding to the APC mRNA inhibits translation, this binding must be relieved in order for the 
accumulated APC mRNA to be translated.  I tested the stability of MSI1 protein and whether it was 
destabilized after removal of Wnt signal from stimulated cells.  MSI1 levels did not change for eight 
hours and stimulation with Wnt did not alter this stability (APC mRNA was stabilized for four to six hours 
after Actinomycin D treatment).  Experiments are under way to answer the questions of how MSI1 
releases the APC mRNA and whether APC mRNA is stabilized as a rapid response to Wnt signal. 
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Finally, to more fully understand the regulatory mechanisms involved in the APC-MSI1 double-
negative feedback circuit, I tested whether c-MYC had an effect on MSI1 expression.  The MYC genes 
comprise a family of the most common human oncogenes, being deregulated in an estimated 70% of all 
cancers [110].  c-MYC is the family member that is most often associated with tissues in which cells 
actively proliferate [117].  There is precedent in the literature for an interaction between c-MYC and 
MSI1 as mice with inducible, intestine specific knock-out of both Apc and c-Myc show less severe 
intestinal phenotypes, including the increased expression of Msi1, compared to mice with Apc knock-out 
only [17, 109].  I tested whether c-MYC could affect expression of MSI1 in human colonocytes and found 
expression of exogenous c-MYC in the system did lead to increased MSI1 levels and expression of a 
dominant negative MYC mutant decreased MSI1 levels (Chapter 4).   Surprisingly, shRNA-induced 
reduction of APC levels in these cells resulted in decreased endogenous c-MYC expression.  These data 
indicated to me that c-MYC has the ability to stimulate MSI1 expression, but that c-MYC is not likely 
functioning to regulate MSI1 under normal cellular conditions.  The implication is that c-MYC 
upregulation of MSI1 may only occur in cancer cells with deregulated c-MYC expression.  
 
Implications of APC-MSI1 Double-negative feedback on Wnt Signal Regulation    
              
With respect to the APC-MSI1 double-negative feedback circuit, there are still unanswered 
questions.  One question is whether or not this double-negative feedback truly acts as a bistable circuit.  
While I have demonstrated the mechanisms involved in the APC-MSI1 interaction, I have not extensively 
evaluated the different cellular states resulting from changes in the balance between APC and MSI1.  For 
example, it is clear that stabilization of β-catenin, either through a Wnt signal or the loss of APC, results 
in an increase in MSI1 which feeds back to inhibit the production of APC.  As previously mentioned, in 
isolation, a double-negative feedback system is bistable, i.e., tipping the balance toward MSI1 would 
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result in self-perpetuation and signal independence.  Studies have demonstrated that upregulation of 
MSI1 leads to decreased differentiation, increased proliferation and tumorigenicity, thus I expect the 
MSI1 dominated, “lights on” state to involve these cellular conditions [69, 78, 88].  In this instance the 
“lights off” state, where the balance is tipped toward APC, would involve cell cycle quiescence and 
differentiation.  Once resultant cellular states are directly linked to the APC-MSI1 double-negative 
feedback circuit, the bistability of the circuit can be evaluated.  Whether or not the opposing cellular 
states are persistent and signal independent is the true test of bistability. 
 A second, and likely more interesting, question about the APC-MSI1 double-negative feedback 
system will follow its establishment as a bistable circuit.  What is the impact of this bistable circuit on 
the homeostasis of the intestinal epithelium?  It is well established that the canonical Wnt signaling 
pathway plays a critical role in homeostasis of the intestinal epithelium [4, 5, 101] and that APC is a key 
component of that pathway [17].  As mentioned in Chapter 1, MSI1 expression is seen in, though not 
restricted to, the stem cell compartment in the intestinal crypt.  Studies of MSI1 in the intestinal 
epithelium have demonstrated the presence of MSI1 in cells at the site of epithelial regeneration and 
indicate the importance of MSI1 in the stem/progenitor cells of the intestinal epithelium [75, 76, 118].  
Isolation of MSI1-expressing cells from disaggregated human colonic crypts led to an enrichment of cells 
with stem cell properties [77].  All of these studies indicate an important role for MSI1 in intestinal stem 
cells.  These cells are critical for the maintenance of homeostasis in the intestinal epithelium under 
normal growth conditions.  The potential bistability associated with the regulation of MSI1 expression 
might be important for the asymmetric stem division and differentiation of the intestinal epithelium.          
The implication that the intracellular regulation of Wnt signaling hinges on a bistable, “toggle-
like”, circuit would have significant impact on our approach to prevention and treatment of colorectal 
cancer.  Elevated levels of Msi1 have been observed in tumors of mice and humans [72, 78].  Further 
study demonstrated the dependence of colorectal cancer cells on MSI1 for their tumorigenic properties 
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[78].  It has been demonstrated that β-catenin stabilization, either through loss of activity of APC or 
other pathway components, leads to transcriptional upregulation of MSI1 ([87], Chapter 2).  We have 
also shown that MSI1 downregulates, in a double-negative feedback fashion, translation of APC, further 
perpetuating the effect of β-catenin transcriptional activation (Chapter 2).  It is well accepted that 
colorectal tumorigenesis is a complex, multistep process.  However, if the initiation of tumorigenesis is a 
bistable, “light switch-like” system, then prevention and/or treatment of colorectal cancer may be as 
simple as finding a signal to “flip the switch”.   
 
Flipping the Switch 
 
 Chapters 3 and 4 were devoted to understanding one way in which the bistable switch implied 
by the APC-MSI1 double-negative feedback circuit is returned to the APC-dominant, or Wnt-off, state.  
The stabilization of the APC mRNA by MSI1 is an intriguing phenomenon.  I hypothesize that this is a 
component of the signal required to turn the Wnt signal “off”, effectively preloading the mRNA in 
preparation for the production of APC protein required to turn off the signal once Wnt has been 
removed.  My data are the first to demonstrate the stabilization of an mRNA target by MSI1.  It will be 
intriguing to study other MSI1 target mRNAs, such as NUMB and CDKN1a (p21), to see if mRNA 
stabilization is a general effect of MSI1 binding or if this is an APC-specific phenomenon.  In terms of 
whether or not this is a part of the response to activation of the Wnt signaling cascade, three important 
steps must follow.  First, it will be important to demonstrate that there is a response of APC production 
after stimulation of the Wnt pathway.  Secondly, it will be important to identify the mechanism by which 
MSI1 releases the APC mRNA after Wnt signal activation.  Finally, it will be important to test whether the 
translational inhibition and mRNA stabilization activities of MSI1 are coupled. 
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The MYC effect 
 
 Of further interest to the regulation of MSI1 expression is the observation that the transcription 
factor, and prevalent oncoprotein, c-MYC has the ability to stimulate MSI1 expression.  Admittedly, 
there is still work to do to demonstrate whether this is a direct effect, i.e., c-MYC binding to the MSI1 
promoter, or a secondary effect, but the implications of our discovery that c-MYC stimulates MSI1 
expression are profound.  Probably most intriguing is the observation that c-MYC expression is not 
stimulated, and in fact is depressed, when APC levels are decreased in our human cell culture system.  
This indicates that under normal cellular conditions, in intestinal epithelium, c-MYC does not participate 
in regulation of MSI1 expression.  Only when c-MYC is overexpressed, or deregulated as it is in 
approximately 70% of all cancers, does it stimulate MSI1 expression.  Based on the data that we have 
collected, the impact of MSI1 upregulation could be dramatic.  We have shown that MSI1 upregulation 
depresses APC expression tipping the homeostatic balance of the cells (Chapter 2).  Based on our data, 
the deregulation of c-MYC would mimick this effect.  Although further experimentation is required to 
establish this effect, we postulate that c-MYC stimulation of MSI1 expression might be a cancer-specific 
phenomenon.   In this case, MSI1 would be upregulated as a part of colorectal tumor initiation (through 
the loss of APC) and also during progression (through the deregulation of c-MYC).  This would mean that 
MSI1 plays a central role throughout colorectal cancer development making it a good candidate as a 
target for therapies. 
 
 
Future Studies 
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 My studies have illuminated a double-negative feedback circuit between APC and MSI1 and 
described the mechanisms of this reciprocal regulation.  While this is valuable information, significant 
questions still remain regarding the functional implications of this double-negative feedback.  Generally, 
it is necessary to perform functional studies in vivo and the definitive studies of this feedback circuit will 
likely involve a mouse model.  However, with the discovery of the stem cells in the intestinal epithelium 
[6-8] a new technique for culturing the intestinal epithelium was established [119].  Stem cells or whole 
crypts are isolated from mouse intestine and placed in 3-dimensional matrix (Matrigel™, BD 
Biosciences).  Under the proper culturing conditions, the isolated epithelium will form a hollow crypt 
organoid structure that develops and turns-over like normal intestinal epithelium [119].  This 3-D crypt 
culturing technique will be extremely useful in evaluating the functional effects of the APC-MSI1 double-
negative feedback circuit on intestinal epithelial homeostasis. 
 Using the crypt culturing system I propose to evaluate the effects of exogenous expression of 
Msi1 on the stem cell compartment.  Introducing exogenous Msi1 specifically into the stem cells will 
allow us to assess the effect of deregulation of Msi1 on proliferation and differentiation in the intestinal 
epithelium.  This will also allow evaluation of bistablilty of the APC-MSI1 interaction in the context of a 
whole epithelial structure.  Transient expression of Msi1 will test whether or not the response is signal 
independent, i.e., does the signal persist in progeny of the cells in which Msi1 was expressed?  All of 
these experiments will help gain a better understanding of the functional effects of the APC-MSI1 
double-negative feedback on homeostasis in the intestinal epithelium. 
 Finally, as mentioned earlier, in vivo models will be important for the evaluation of the APC-
MSI1 double-negative feedback circuit, especially as it pertains to tumorigenesis.  We have acquired 
Msi1-/- mice and have plans to breed them with standard intestinal cancer models carrying Apc 
mutations.  Comparing tumorigenesis in Apc mouse models with and without Msi1 will allow direct 
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genetic examination of the role of the APC-MSI1 double-negative feedback circuit in intestinal 
tumorigenesis.  
 
 In summary, I have identified a novel double-negative feedback circuit between the tumor 
suppressor APC and the sequence-specific RNA binding protein MSI1 in the intestinal epithelium.  This 
double-negative feedback is involved in regulation of the canonical Wnt signaling pathway and may 
confer bistability onto this already complex signal transduction pathway.  Given the bistable nature of 
double-negative feedback, strong signals are required to reverse the effect of stimulation of the Wnt 
signaling pathway.  The first part of this signal may be the stabilization and accumulation of APC mRNA 
in Wnt stimulated cells followed by the release and subsequent translation of APC when Wnt signal is 
removed.  Finally, a prevalent oncoprotein, c-MYC, has the ability to stimulate MSI1 expression.  This 
stimulation does not seem to occur under normal cellular conditions and we speculate that it is a 
cancer-specific response.  Taken together, these data have expanded our understanding of the 
molecular mechanisms involved in regulation of the canonical Wnt signaling pathway and the 
maintenance of homeostasis in the intestinal epithelium.  With this knowledge, we have gained insight 
into the molecular basis of colorectal cancer.  It is our hope that one day these basic, molecular 
principles will be applied to the clinical setting for the development of improved prevention and 
treatment plans for colorectal cancer.   
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